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I.  General Information 
 
The following reagents were purchased and used as received: NiCl2glyme (Strem), ligand 1 
(Aldrich), ZnCl2 (Aldrich; reagent grade, ≥98%), diglyme (Aldrich; anhydrous), n-BuLi (Aldrich; 
2.5 M in hexanes).  All aryl bromides were purchased (Aldrich, Alfa Aesar, TCI, and Oakwood) 
and used as received.  Anhydrous THF was purified and dried using a solvent-purification 
system that contained activated alumina. 
All reactions were carried out in oven-dried glassware under an inert atmosphere. 
HPLC analyses were carried out on an Agilent 1100 Series system, using Daicel 
CHIRALCEL® columns or Daicel CHIRALPAK® columns (internal diameter 4.6 mm, column 
length 250 mm, particle size 5 "m). 
1H NMR data and 13C NMR data were collected on a Varian 500 MHz spectrometer at 




II.      Preparation  of  Electrophiles  
 













General Procedure A 
Preparation of the ketone using a Grignard reagent.  A solution of the Grignard reagent in 
THF (1.0 M, 40 mmol; 1.0 equiv) was added by syringe to a solution of the Weinreb amide1 (40 
mmol) in THF (20 mL) at 0 °C.  The reaction mixture was stirred at 0 °C for 15 min, and then it 
was allowed to warm to r.t. and stirred for 15 h.  Next, water was added to quench the reaction 
at 0 °C.  A solution of 1 N HCl (50 mL) was added, and then the mixture was extracted with 
CH2Cl2 (3 × 50 mL).  The organic layers were combined, dried over Na2SO4, and concentrated.  
The crude product was purified by flash chromatography on silica gel. 
Reduction of the ketone to the alcohol.  NaBH4 (2.3 g, 60 mmol; 3.0 equiv) was added in 
portions to a solution of the ketone (20 mmol) in Et2O (20 mL) and MeOH (20 mL) at 0 °C 
(CAUTION: very exothermic).  After the addition was complete, the mixture was stirred at 0 
°C for 30 min, and then it was allowed to warm to r.t. and stirred for 30 min.  Next, Et2O (30 
mL) was added to dilute the reaction mixture, the mixture was cooled to 0 °C, and then 
deionized water (30 mL) was added to quench the reaction.  The mixture was extracted with 
CH2Cl2 (3 × 50 mL), and the combined organic layers were dried over Na2SO4 and concentrated.  
The crude product was purified by flash chromatography on silica gel. 
Bromination  of  the  alcohol.2      Triphenylphosphite  (4.0  g,  3.4  mL;  1.3  equiv)  was  added  over  
5  min  to  a  solution  of  N-­‐‑bromosuccinimide  (2.3  g,  13  mmol;  1.3  equiv)  in  CH2Cl2  (10  mL)  at  0  °C  
(CAUTION: exothermic).      Next,  a  solution  of  the  alcohol  (10  mmol)  in  CH2Cl2  (12  mL)  was  
added  to  the  mixture  at  0  °C.      The  reaction  mixture  was  heated  to  40  °C  and  then  stirred  at  40  
°C  for  12  h.      Next,  the  solvent  was  evaporated,  and  the  product  was  purified  by  flash  
chromatography  on  silica  gel.  
 
 









General Procedure B 
Swern oxidation of the alcohol.  DMSO (2.9 mL, 40 mmol; 2.0 equiv) was added slowly to 
a solution of oxalyl chloride (2.0 mL, 24 mmol; 1.2 equiv) in CH2Cl2 (150 mL) at −78 °C.  The 
resulting mixture was allowed to stir at −78 °C for 30 min.  Next, a solution of the alcohol (20 
                                                
(1) Prepared from the corresponding acid anhydride, acid chloride, or ester, based on 
published procedures: (a) Regan, J. et al. J. Med. Chem. 2006, 49, 7887–7896.  (b) Bergeron, 
M.; Johnson, T.; Paquin, J.-F. Angew. Chem. Int. Ed. 2011, 50, 11112–11116. 
(2) Bose, A. K.; Lal, B. Tetrahedron Lett. 1973, 14, 3937–3940. 
 S–3 
mmol) in CH2Cl2 (30 mL) was added over 5 min to the mixture.  The resulting mixture was 
stirred at −78 °C for 45 min, and then NEt3 (11 mL, 80 mmol; 4.0 equiv) was added in one 
portion.  The mixture was allowed to warm to r.t., and then it was stirred at r.t. for 2 h.  Next, 
an aqueous saturated solution of NH4Cl (30 mL) was added to quench the reaction.  The 
resulting mixture was extracted with CH2Cl2 (3 × 70 mL), and the combined organic layers were 
dried over Na2SO4 and concentrated.  The crude product was purified by flash 
chromatography on silica gel. 
Trifluoromethylation of the aldehyde.3  A solution of TBAF (1.0 M in THF; 0.20 mL, 0.20 
mmol; 0.013 equiv) was added over 3 min to a solution of the aldehyde (15 mmol) and 
trifluoromethyltrimethylsilane (2.7 mL, 18 mmol; 1.2 equiv) in THF (20 mL) at 0 °C (CAUTION: 
very exothermic).  The reaction mixture was allowed to warm to r.t., and it was stirred for 1 h.  
Next, an aqueous solution of 1 N HCl (30 mL) was added, and the mixture was allowed to stir at 
r.t. for another 2 h.  Then, the mixture was extracted with CH2Cl2 (3 × 50 mL), and the 
combined organic layers were dried over Na2SO4 and concentrated.  The crude product was 
purified by flash chromatography on silica gel. 
The bromination step is the same as in General Procedure A. 
 
 









General Procedure C 
The first two steps are the same as in General Procedure B. 
Bromination of the alcohol.4  Triphenylphosphine (4.2 g, 16 mmol; 2.0 equiv) and 
tetrabromomethane (5.3 g, 16 mmol; 2.0 equiv) were added to a solution of the alcohol (8.0 
mmol) in toluene (20 mL).  The resulting mixture was heated to 110 °C and stirred at 110 °C for 
3 h, at which time it had turned into a yellow suspension.  Then, CH2Cl2 (50 mL) was added to 
the reaction mixture until it became a clear solution.  The solvents were then evaporated, and 






(3-Bromo-4,4,4-trifluorobutyl)benzene [136832-35-4].  The title compound was synthesized 
according to General Procedure A, using 2,2,2-trifluoro-N-methoxy-N-methylacetamide and a 
Grignard reagent prepared from (2-bromoethyl)benzene.  The overall yield was 34% (3 steps).  
The title compound was isolated as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 7.37 – 7.32 (m, 2H), 7.29 – 7.22 (m, 3H), 4.03 – 3.96 (m, 1H), 3.02 
(ddd, 1H, J = 13.4, 8.3, 4.6 Hz), 2.81 – 2.75 (m, 1H), 2.40 – 2.33 (m, 1H), 2.21 (dddd, 1H, J = 14.6, 
11.0, 8.2, 4.6 Hz); 
                                                
(3) Krishnamurti, R.; Bellew, D. R.; Prakash, G. K. S. J. Org. Chem. 1991, 56, 984−989. 
(4) Lin, X.; Zheng, F.; Qing, F.-L. Organometallics 2012, 31, 1578–1582. 
 S–4 
13C NMR (126 MHz, CDCl3) δ 139.2, 128.8, 128.5, 126.7, 124.0 (q, J = 278.2 Hz), 46.7 (q, J = 32.6 
Hz), 32.9 (d, J = 1.4 Hz), 32.5; 
19F NMR (282 MHz, CDCl3) δ −72.1 (d, 3F, J = 7.1 Hz); 
FT-IR (film) 3029, 1258, 1168, 1111, 750, 700 cm-1; 






2-Bromo-1,1,1-trifluoropropane [421-46-5].  The title compound was synthesized from 
1,1,1-trifluoropropan-2-ol according to a literature procedure5 in 68% yield (colorless oil; it 
should be stored in a refrigerator (~5 °C)). 
1H NMR (500 MHz, CDCl3) δ 4.21 (hept, 1H, J = 7.0 Hz), 1.81 (d, 3H, J = 7.0 Hz); 






(2-Bromo-3,3,3-trifluoropropyl)cyclohexane.  The title compound was synthesized 
according to General Procedure B, using 3-cyclohexyl-1,1,1-trifluoropropan-2-ol, in 46% yield 
(colorless oil). 
1H NMR (500 MHz, CDCl3) δ 4.16 (dqd, 1H, J = 3.7, 7.1, 10.8 Hz), 1.88 – 1.65 (m, 7H), 1.65 – 
1.56 (m, 1H), 1.35 – 1.24 (m, 2H), 1.23 – 1.11 (m, 1H), 1.08 – 1.00 (m, 1H), 0.87 – 0.79 (m, 1H); 
13C NMR (126 MHz, CDCl3) δ 124.3 (q, J = 277.8 Hz), 45.5 (q, J = 32.4 Hz), 38.4, 34.5, 33.7, 31.0, 
26.3, 26.1, 25.7; 
19F NMR (282 MHz, CDCl3) δ −72.5 (d, 3F, J = 7.0 Hz); 
FT-IR (film) 2925, 2854, 1450, 1314, 1291, 1271, 1258, 1180, 1157, 1128, 1109, 681 cm-1; 






2-Bromo-1,1,1-trifluorodecane [1349717-60-7].  The title compound was synthesized 
according to General Procedure A, using 2,2,2-trifluoro-N-methoxy-N-methylacetamide and a 
Grignard reagent prepared from 1-bromooctane.  The overall yield was 30% (3 steps).  The 
title compound was isolated as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 4.06 (dqd, 1H, J = 10.5, 7.2, 3.3 Hz), 2.02 (dddd, 1H, J = 14.6, 9.8, 
6.1, 3.3 Hz), 1.91 – 1.81 (m, 1H), 1.43 – 1.21 (m, 12H), 0.89 (t, 3H, J = 7.2 Hz); 
                                                
(5) Ullmann, J.; Hanack, M. Synthesis 1989, 685–687. 
(6) Hanack, M.; Ullmann, J. J. Org. Chem. 1989, 54, 1432–1435. 
 S–5 
13C NMR (126 MHz, CDCl3) δ 124.1 (q, J = 278.0 Hz), 47.7 (q, J = 32.3 Hz), 31.8, 31.4 (d, J = 1.5 
Hz), 29.23, 29.15, 28.6, 26.8, 22.6, 14.1; 
19F NMR (282 MHz, CDCl3) δ −72.4 (d, 3F, J = 7.2 Hz); 
FT-IR (film) 2956, 2928, 2857, 1266, 1173, 1124, 1105, 678 cm-1; 






((6-Bromo-7,7,7-trifluoroheptyl)oxy)(tert-butyl)diphenylsilane.  The title compound was 
synthesized according to General Procedure B from 6-((tert-butyldiphenylsilyl)oxy)hexan-1-ol.7  
The overall yield was 23% (3 steps).  The title compound was isolated as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 7.70 – 7.66 (m, 4H), 7.46 – 7.37 (m, 6H), 4.04 (dqd, 1H, J = 10.5, 
7.2, 3.4 Hz), 3.69 (t, 2H, J = 6.3 Hz), 2.02 (dddd, 1H, J = 14.4, 9.8, 5.6, 3.3 Hz), 1.90 – 1.81 (m, 1H), 
1.69 – 1.54 (m, 3H), 1.49 – 1.35 (m, 3H), 1.07 (s, 9H); 
13C NMR (126 MHz, CDCl3) δ 135.6, 134.0, 129.6, 127.6, 124.1 (q, J = 278.2 Hz), 63.5, 47.6 (q, J = 
32.4 Hz), 32.1, 31.4 (d, J = 1.4 Hz), 26.9, 26.5, 24.9, 19.2; 
19F NMR (282 MHz, CDCl3) δ −72.3 (d, 3F, J = 7.1 Hz); 
FT-IR (film) 2932, 2858, 1428, 1259, 1171, 1113, 823, 701 cm-1; 






2-Bromo-6-chloro-1,1,1-trifluorohexane.  The title compound was synthesized according to 
General Procedure B, using 6-chloro-1,1,1-trifluorohexan-2-ol, in 44% yield (colorless oil). 
1H NMR (500 MHz, CDCl3) δ 4.08 (dqd, 1H, J = 3.3, 7.1, 10.5 Hz), 3.58 – 3.55 (m, 2H), 2.11 – 
2.04 (m, 1H), 1.94 – 1.78 (m, 4H), 1.66 – 1.57 (m, 1H); 
13C NMR (126 MHz, CDCl3) δ 123.9 (q, J = 278.1 Hz), 47.2 (q, J = 32.6 Hz), 44.3, 31.5, 30.8 (d, J 
= 1.5 Hz), 24.3; 
19F NMR (282 MHz, CDCl3) δ −72.3 (d, 3F, J = 7.1 Hz); 
FT-IR (film) 2957, 1330, 1259, 1167, 1111, 677 cm-1; 
GC-MS (EI) m/z (M+−HBr) calcd for C6H8ClF3: 172, found: 172. 
 
 
                                                
(7) Prepared according to a literature procedure: Yuan, H.; He, R.; Wan, B.; Wang, Y.; Pauli, G. 





2,10-Dibromo-1,1,1-trifluorodecane.  The title compound was synthesized according to 
General Procedure B from 9-bromononan-1-ol.  The overall yield was 50% (3 steps).  The title 
compound was isolated as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 4.06 (dqd, 1H, J = 10.5, 7.1, 3.3 Hz), 3.41 (t, 2H, J = 6.8 Hz), 2.02 
(dddd, 1H, J = 14.5, 9.8, 6.1, 3.3 Hz), 1.89 – 1.82 (m, 3H), 1.47 – 1.28 (m, 10H); 
13C NMR (126 MHz, CDCl3) δ 124.0 (q, J = 278.2 Hz), 47.7 (q, J = 32.4 Hz), 33.9, 32.7, 31.3 (d, J 
= 1.5 Hz), 29.0, 28.56, 28.48, 28.0, 26.7; 
19F NMR (282 MHz, CDCl3) δ −72.3 (d, 3F, J = 7.1 Hz); 
FT-IR (film) 2931, 2857, 1267, 1169, 1110, 677 cm-1; 






6-Bromo-7,7,7-trifluoroheptyl 4-methylbenzenesulfonate.  The title compound was 
synthesized according to General Procedure B from 6-hydroxyhexyl 4-methylbenzenesulfonate.8  
The overall yield was 52% (3 steps).  The title compound was isolated as a colorless oil. 
1H NMR (500 MHz, CD3COCD3) δ 7.83 – 7.79 (m, 2H), 7.51 – 7.46 (m, 2H), 4.55 (dqd, 1H, J = 
10.7, 7.4, 3.3 Hz), 4.07 (t, 2H, J = 6.3 Hz), 2.46 (s, 3H), 2.04 – 1.99 (m, 1H), 1.85 – 1.76 (m, 1H), 1.73 
– 1.55 (m, 3H), 1.52 – 1.30 (m, 3H); 
13C NMR (126 MHz, CD3COCD3) δ 145.9, 134.5, 131.0, 128.8, 125.5 (q, J = 277.2 Hz), 71.4, 48.4 
(q, J = 32.0 Hz), 32.0 (d, J = 1.6 Hz), 29.3, 26.9, 25.2, 21.6; 
19F NMR (282 MHz, CD3COCD3) δ −72.9 (d, 3F, J = 7.4 Hz); 
FT-IR (film) 2948, 1598, 1359, 1189, 1176, 1117, 1098, 951, 815, 664 cm-1; 









1-(4-((6-Bromo-7,7,7-trifluoroheptyl)oxy)phenyl)ethan-1-one.  The title compound was 
synthesized according to General Procedure C from 1-(4-((6-hydroxyhexyl)oxy)phenyl)ethan-1-
one.9  The overall yield was 57% (3 steps).  The title compound was isolated as a light-yellow 
oil (it should be stored in a refrigerator (~5 °C)). 
                                                
(8) Prepared according to a literature procedure: Shaikh, T. M.; Sudalai, A. Eur. J. Org. Chem. 
2010, 3437–3444. 
(9) Prepared from 6-chlorohexan-1-ol and 1-(4-hydroxyphenyl)ethan-1-one. 
 S–7 
1H NMR (500 MHz, CDCl3) δ 7.94 – 7.90 (m, 2H), 6.93 – 6.89 (m, 2H), 4.12 – 4.05 (m, 1H), 4.03 
(t, 2H, J = 6.3 Hz), 2.55 (s, 3H), 2.07 (dddd, 1H, J = 14.4, 10.1, 5.6, 3.4 Hz), 1.94 – 1.80 (m, 3H), 1.78 
– 1.68 (m, 1H), 1.62 – 1.47 (m, 3H); 
13C NMR (126 MHz, CDCl3) δ 196.7, 162.9, 130.6, 130.2, 124.0 (q, J = 278.2 Hz), 114.0, 67.8, 47.4 
(q, J = 32.4 Hz), 31.3 (d, J = 1.4 Hz), 28.7, 26.5, 26.3, 25.2; 
19F NMR (282 MHz, CDCl3) δ −72.3 (d, 3F, J = 7.1 Hz); 
FT-IR (film) 2946, 2867, 1676, 1602, 1576, 1509, 1358, 1257, 1172, 1117, 834 cm-1; 








1-((6-Bromo-7,7,7-trifluoroheptyl)oxy)-4-iodobenzene.  The title compound was 
synthesized according to General Procedure B from 6-(4-iodophenoxy)hexan-1-ol.10  The 
overall yield was 33% (3 steps).  The title compound was isolated as a colorless oil (it should be 
stored in a refrigerator (~5 °C)). 
1H NMR (500 MHz, CDCl3) δ 7.57 – 7.52 (m, 2H), 6.69 – 6.65 (m, 2H), 4.08 (dqd, 1H, J = 10.5, 
7.1, 3.4 Hz), 3.93 (t, 2H, J = 6.3 Hz), 2.07 (dddd, 1H, J = 14.3, 9.9, 5.5, 3.4 Hz), 1.95 – 1.86 (m, 1H), 
1.85 – 1.68 (m, 3H), 1.60 – 1.46 (m, 3H); 
13C NMR (126 MHz, CDCl3) δ 158.8, 138.2, 124.0 (q, J = 278.2 Hz), 116.9, 82.6, 67.6, 47.5 (q, J = 
32.5 Hz), 31.3 (d, J = 1.4 Hz), 28.8, 26.6, 25.2; 
19F NMR (282 MHz, CDCl3) δ −72.3 (d, 3F, J = 7.1 Hz); 
FT-IR (film) 2944, 1587, 1487, 1473, 1283, 1245, 1175, 1117, 820 cm-1; 







tert-Butyl 4-(2-bromo-3,3,3-trifluoropropyl)piperidine-1-carboxylate.  The title compound 
was synthesized according to General Procedure C from tert-butyl 4-(2-
hydroxyethyl)piperidine-1-carboxylate.  The overall yield was 26% (3 steps).  The title 
compound was isolated as a white solid. 
1H NMR (500 MHz, CDCl3) δ 4.15 – 4.09 (m, 3H), 2.72 – 2.68 (m, 2H), 1.94 – 1.85 (m, 1H), 1.85 
– 1.72 (m, 2H), 1.68 – 1.63 (m, 2H), 1.44 (s, 9H), 1.23 (tdd, 1H, J = 12.8, 11.0, 4.4 Hz), 1.03 (tdd, 1H, 
J = 12.7, 11.0, 4.5 Hz); 
13C NMR (126 MHz, CDCl3) δ 154.7, 124.1 (q, J = 278.1 Hz), 79.5, 44.8 (q, J = 32.7 Hz), 37.6, 
33.2, 32.4, 30.0, 28.4; 
19F NMR (282 MHz, CDCl3) δ −72.5 (d, 3F, J = 7.0 Hz); 
FT-IR (film) 2977, 2931, 2850, 1691, 1425, 1366, 1262, 1252, 1172, 1129, 1110, 967, 685 cm-1; 
                                                
(10) Prepared from 6-chlorohexan-1-ol and 4-iodophenol. 
 S–8 








6-Bromo-7,7,7-trifluoroheptyl furan-2-carboxylate.  The title compound was synthesized 
according to General Procedure B from 6-hydroxyhexyl furan-2-carboxylate.11  The overall 
yield was 62% (3 steps).  The title compound was isolated as a light-yellow oil (it should be 
stored in a refrigerator (~5 °C)). 
1H NMR (500 MHz, CDCl3) δ 7.57 (dd, 1H, J = 1.8, 0.9 Hz), 7.17 (dd, 1H, J = 3.5, 0.9 Hz), 6.51 
(dd, 1H, J = 3.5, 1.7 Hz), 4.31 (t, 2H, J = 6.6 Hz), 4.07 (dqd, 1H, J = 10.5, 7.1, 3.4 Hz), 2.05 (dddd, 
1H, J = 14.7, 10.3, 5.6, 3.3 Hz), 1.93 – 1.84 (m, 1H), 1.82 – 1.68 (m, 3H), 1.55 – 1.42 (m, 3H); 
13C NMR (126 MHz, CDCl3) δ 158.7, 146.3, 144.7, 124.0 (q, J = 278.1 Hz), 117.8, 111.8, 64.6, 47.4 
(q, J = 32.5 Hz), 31.3 (d, J = 1.5 Hz), 28.4, 26.5, 25.1; 
19F NMR (282 MHz, CDCl3) δ −72.3 (d, 3F, J = 7.0 Hz); 
FT-IR (film) 2949, 2866, 1726, 1582, 1571, 1475, 1400, 1297, 1260, 1180, 1118, 1014, 958, 885, 
764, 677 cm-1; 






(4,4,4-Trifluoro-3-iodobutyl)benzene.  The title compound was synthesized according to 
General Procedure A, using 1,1,1-trifluoro-4-phenylbutan-2-ol, in 48% yield (colorless oil; it 
should be stored in a refrigerator (~5 °C)); N-iodosuccinimide, rather than N-bromosuccinimide, 
was used. 
1H NMR (500 MHz, CDCl3) δ 7.35 – 7.31 (m, 2H), 7.28 – 7.22 (m, 3H), 4.09 – 4.00 (m, 1H), 3.00 
(dt, 1H, J = 6.4, 13.4 Hz), 2.71 (dt, 1H, J = 8.2, 13.9 Hz), 2.23 – 2.16 (m, 2H); 
13C NMR (126 MHz, CDCl3) δ 139.1, 128.8, 128.5, 126.7, 124.6 (q, J = 276.5 Hz), 34.4, 34.2 (d, J 
= 1.6 Hz), 23.6 (q, J = 31.1 Hz); 
19F NMR (282 MHz, CDCl3) δ −68.8 (d, 3F, J = 8.0 Hz); 
FT-IR (film) 3028, 1455, 1257, 1161, 1094, 1075, 749 cm-1; 






(3-Bromo-4,4,5,5,6,6,6-heptafluorohexyl)benzene.  The title compound was synthesized 
according to General Procedure A, using 2,2,3,3,4,4,4-heptafluoro-N-methoxy-N-
                                                
(11) Prepared from hexane-1,6-diol and furan-2-carbonyl chloride. 
 S–9 
methylbutanamide and a Grignard reagent prepared from (2-bromoethyl)benzene.  The overall 
yield was 24% (3 steps).  The title compound was isolated as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 7.35 – 7.32 (m, 3H), 7.28 – 7.22 (m, 2H), 4.19 – 4.08 (m, 1H), 3.06 
(ddd, 1H, J = 13.3, 8.4, 4.4 Hz), 2.80 (dt, 1H, J = 13.9, 8.2 Hz), 2.43 – 2.36 (m, 1H), 2.27 – 2.17 (m, 
1H); 
13C NMR (126 MHz, CDCl3) δ 139.1, 128.8, 128.5, 126.7, 121.5 – 108.5 (m), 46.5 (t, J = 24.5 Hz), 
32.6, 32.3; 
19F NMR (282 MHz, CDCl3) δ −80.8 (t, 3F, J = 10.7 Hz), −109.2 – −115.5 (m, 2F), –123.3 (dd, 2F, 
J = 20.0, 8.1 Hz); 
FT-IR (film) 3029, 2936, 1497, 1456, 1348, 1235, 1182, 1108, 964, 927, 750, 724, 699 cm-1; 






(3-Bromo-4-chloro-4,4-difluorobutyl)benzene.  The title compound was synthesized 
according to General Procedure A, using 1-chloro-1,1-difluoro-4-phenylbutan-2-ol, in 48% yield 
(colorless oil). 
1H NMR (500 MHz, CDCl3) δ 7.35 – 7.32 (m, 2H), 7.27 – 7.23 (m, 3H), 4.12 (tdd, 1H, J = 2.6, 
5.6, 11.1 Hz), 3.04 (ddd, 1H, J = 4.5, 8.3, 13.3 Hz), 2.78 (dt, 1H, J = 8.3, 13.9 Hz), 2.50 – 2.43 (m, 
1H), 2.22 (dddd, 1H, J = 4.4, 8.1, 11.0, 14.5 Hz); 
13C NMR (126 MHz, CDCl3) δ 139.3, 128.7, 128.5, 127.6 (dd, J = 292.5, 294.2 Hz), 126.7, 53.7 (t, 
J = 27.0 Hz), 34.2, 32.6; 
19F NMR (282 MHz, CDCl3) δ −53.7 (dd, 1F, J = 5.7, 162.3 Hz), −57.5 (dd, 1F, J = 11.1, 162.4 
Hz); 
FT-IR (film) 3029, 2929, 1497, 1455, 1256, 1203, 1169, 1116, 1080, 1031, 947, 751, 699 cm-1; 









3-Bromo-2,2-difluoro-1,5-diphenylpentan-1-one.  The title compound was synthesized 
according to General Procedure B, using 2,2-difluoro-3-hydroxy-1,5-diphenylpentan-1-one,12 in 
44% yield (colorless oil). 
1H NMR (500 MHz, CDCl3) δ 8.07 – 8.05 (m, 2H), 7.67 – 7.64 (m, 1H), 7.52 – 7.48 (m, 2H), 7.34 
– 7.30 (m, 2H), 7.27 – 7.22 (m, 3H), 4.46 (dtd, 1H, J = 2.6, 11.1, 14.9 Hz), 3.08 (ddd, 1H, J = 4.5, 8.7, 
13.5 Hz), 2.80 (dt, 1H, J = 8.3, 13.9 Hz), 2.45 – 2.38 (m, 1H), 2.30 – 2.22 (m, 1H); 
                                                
(12)  Prepared in two steps based on literature procedures: (a) Ammi, H.; Kobayashi, T.; 
Hatamoto, Y.; Uneyama, K. Chem. Commun. 1999, 1323–1324.  (b) Lefebvre, O.; Brigaud, T.; 
Portella, C. J. Org. Chem. 2001, 66, 1941–1946. 
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13C NMR (126 MHz, CDCl3) δ 188.3 (dd, J = 28.9, 30.6 Hz), 139.6, 134.4, 132.2 (t, J = 2.3 Hz), 
130.0 (dd, J = 2.7, 4.1 Hz), 128.7, 128.6, 128.5, 126.4, 116.1 (dd, J = 256.9, 261.0 Hz), 49.6 (dd, J = 
24.1, 26.9 Hz), 32.8, 32.2 (t, J = 2.2 Hz); 
19F NMR (282 MHz, CDCl3) δ −101.1 (dd, 1F, J = 11.1, 275.8 Hz), −105.7 (dd, 1F, J = 14.9, 275.7 
Hz); 
FT-IR (film) 3063, 3028, 2930, 1702, 1598, 1497, 1449, 1281, 1251, 1203, 1185, 1046, 923, 898, 
754, 717, 700, 687 cm-1; 








Ethyl 3-bromo-2,2-difluoro-5-phenylpentanoate.  The title compound was synthesized 
according to General Procedure B, using ethyl 2,2-difluoro-3-hydroxy-5-phenylpentanoate,13 in 
87% yield (colorless oil). 
1H NMR (500 MHz, CDCl3) δ 7.34 – 7.31 (m, 2H), 7.26 – 7.21 (m, 3H), 4.35 (q, 2H, J = 7.1 Hz), 
4.23 – 4.15 (m, 1H), 3.03 (ddd, 1H, J = 4.6, 8.5, 13.5 Hz), 2.76 (dt, 1H, J = 8.3, 13.9 Hz), 2.36 – 2.29 
(m, 1H), 2.20 (dddd, 1H, J = 4.6, 8.5, 11.1, 14.8 Hz), 1.34 (t, 3H, J = 7.1 Hz); 
13C NMR (126 MHz, CDCl3) δ 162.2 (t, J = 32.3 Hz), 139.6, 128.7, 128.5, 126.5, 113.5 (dd, J = 
253.1, 258.0 Hz), 63.4, 49.2 (dd, J = 25.5, 28.0 Hz), 32.7, 31.9, 13.8; 
19F NMR (282 MHz, CDCl3) δ −105.1 (dd, 1F, J = 9.0, 255.8 Hz), −114.4 (dd, 1F, J = 15.9, 255.8 
Hz); 
FT-IR (film) 3028, 2984, 1776, 1760, 1497, 1455, 1373, 1311, 1251, 1218, 1102, 1061, 753, 700 cm-
1; 
GC-MS (EI) m/z (M+) calcd for C13H1579BrF2O2: 320, found: 320, 322 (M++2). 
 
 
                                                
(13) Prepared according to a literature procedure: Welch, M.; Dutton, J. M.; Glansdorp, F. G.; 
Thomas, G. L.; Smith, D. S.; Coulthurst, S. J.; Barnard, A. M. L.; Salmond, G. P. C.; Spring, 
D. R. Bioorg. Med. Chem. Lett. 2005, 15, 4235–4238. 
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 III.  Stereoconvergent Negishi Cross-Couplings 
 
General procedure for the preparation of a solution of the arylzinc reagent (0.30 M): ZnCl2 
(Aldrich; reagent grade, ≥98%) was fused through drying with a heat gun under high vacuum 
for 20 min before use.  n-BuLi (Aldrich; ~2.5 M in hexanes) was titrated using diphenylacetic 
acid, according to Kofron’s method.14 
In the air, ZnCl2 (1.43 g, 10.5 mmol) was added quickly to an oven-dried 20 mL vial 
equipped with a stir bar.  The vial was closed with a PTFE septum cap, and then it was 
evacuated and back-filled with nitrogen (three cycles).  THF (6.0 mL) was added to the vial, 
and the resulting mixture was stirred vigorously until the ZnCl2 had completely dissolved.  
THF (0.5 mL) was then added, thereby providing a 1.50 M solution of ZnCl2.  Next, an oven-
dried 40 mL vial equipped with a stir bar was charged with the aryl bromide (9.00 mmol), and 
then it was closed with a PTFE septum cap.  The vial was next evacuated and back-filled with 
nitrogen (three cycles), and then THF (6.5 mL) was added to this vial.  The vial that contained 
the solution of the aryl bromide was cooled to −78 °C.  A solution of n-BuLi in hexanes (2.57 M; 
3.50 mL, 9.00 mmol; 1.00 equiv) was added over ~4 min to the solution of the aryl bromide.  
After the addition was complete, the resulting mixture was stirred at −78 °C for 7 min.  Next, 
the solution of ZnCl2 (1.50 M; 6.00 mL, 9.00 mmol; 1.00 equiv) was added to the vial.  The 
resulting mixture was allowed to warm to r.t., and then it was stirred for 45 min at r.t.  The 
solution of the arylzinc reagent was titrated using I2, according to Knochel’s method15 (the 
concentration was typically ~0.4 M).  This solution was then diluted to a 0.30 M solution using 
THF. 
These solutions of organozinc reagents can be stored at r.t. under an inert atmosphere for 
several weeks without deterioration. 
General Procedure for stereoconvergent Negishi arylations: In the air, an oven-dried 20 mL 
vial equipped with a stir bar was charged with the electrophile (1.00 mmol).  The vial was 
closed with a PTFE septum cap, and then it was evacuated and back-filled with nitrogen (three 
cycles).  In the air, NiCl2⋅glyme (13.2 mg, 0.060 mmol) and (R,R)-1 (26.1 mg, 0.078 mmol) were 
added to an oven-dried 4 mL vial equipped with a stir bar.  The vial was closed with a PTFE 
septum cap, and then it was evacuated and back-filled with nitrogen (three cycles).  Diglyme 
(1.5 mL) was added to the vial, and the mixture was vigorously stirred at r.t. for 30 min.  The 
resulting solution was transferred via syringe to the 20 mL reaction vial that contained the 
electrophile.  The 4 mL vial was rinsed with THF three times (0.8 mL, 0.8 mL, and 0.7 mL), and 
the washings were transferred to the reaction vial.  The resulting solution was stirred at r.t. for 
3 min.  Then, the joint of the reaction vial was wrapped with electrical tape, and the vial was 
cooled to −20 °C.  Meanwhile, an oven-dried 40 mL vial that contained the solution of the 
arylzinc reagent was also cooled to −20 °C.  Nitrogen-filled balloons were attached to both of 
the vials.  To the vigorously stirred solution of catalyst and electrophile was added the solution 
of the arylzinc reagent (0.30 M; 5.0 mL, 1.5 mmol; 1.5 equiv) over 3 min, leading to an orange 
reaction mixture.  The balloon was removed, and the puncture hole in the septum cap was 
covered with grease.  The mixture was stirred vigorously at −20 °C for 14 h, and then the 
reaction was quenched by the addition of MeOH (2 mL).  The resulting mixture was allowed to 
                                                
(14)  Kofron, W. G.; Baclawski, L. M. J. Org. Chem. 1976, 41, 1879−1880. 
(15)  Krasovskiy, A.; Knochel, P. Synthesis 2006, 890−891. 
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warm to r.t., and then it was diluted with Et2O (100 mL) and washed with deionized water (20 
mL × 4).  The organic layer was dried over Na2SO4, filtered, and then concentrated, and the 
residue was purified by flash chromatography. 






(R)-1-Methoxy-2-(1,1,1-trifluoro-4-phenylbutan-2-yl)benzene (Table 2, Entry 1).  (3-
Bromo-4,4,4-trifluorobutyl)benzene (267 mg, 1.00 mmol) and an arylzinc chloride reagent 
prepared from 1-bromo-2-methoxybenzene were used.  The reaction was run at −20 °C for 40 
h.  Solvent system for chromatography: 15:1 hexane/dichloromethane.  The title compound 
was isolated as a colorless oil. 
Run 1, 150 mg (51% yield, 88% ee); Run 2, 140 mg (48% yield, 86% ee). 
The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 0.5 mL/min); 
retention times for compound obtained using (R,R)-1: 15.5 min (minor), 16.4 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.41 – 7.39 (m, 1H), 7.33 (ddd, 1H, J = 1.7, 7.4, 8.2 Hz), 7.30 – 
7.26 (m, 2H), 7.22 – 7.18 (m, 1H), 7.11 – 7.09 (m, 2H), 7.03 (td, 1H, J = 1.1, 7.5 Hz), 6.95 (dd, 1H, J 
= 1.1, 8.3 Hz), 4.08 (dqd, 1H, J = 4.2, 9.7, 11.2 Hz), 3.82 (s, 3H), 2.57 – 2.44 (m, 2H), 2.33 (dddd, 
1H, J = 4.2, 7.1, 9.8, 13.4 Hz), 2.18 (dddd, 1H, J = 5.1, 9.5, 11.0, 13.5 Hz); 
13C NMR (126 MHz, CDCl3) δ 158.0, 141.1, 129.0, 128.4, 128.3, 128.2, 127.2 (q, J = 280.9 Hz), 
126.0, 123.1, 120.8, 110.9, 55.6, 39.8 (q, J = 27.2 Hz), 32.6, 30.4 (d, J = 2.5 Hz); 
19F NMR (282 MHz, CDCl3) δ −69.5 (d, 3F, J = 9.6 Hz); 
FT-IR (film) 2941, 1603, 1496, 1464, 1246, 1148, 1118, 1030, 753, 699 cm-1; 
GC-MS (EI) m/z (M+) calcd for C17H17F3O: 294, found: 294; 






(R)-1-Methoxy-3-(1,1,1-trifluoro-4-phenylbutan-2-yl)benzene (Table 2, Entry 2).  (3-
Bromo-4,4,4-trifluorobutyl)benzene (267 mg, 1.00 mmol) and an arylzinc chloride reagent 
prepared from 1-bromo-3-methoxybenzene were used.  Solvent system for chromatography: 
5:1 → 4:1 hexane/dichloromethane.  The title compound was isolated as a colorless oil. 
Run 1, 268 mg (91% yield, 96% ee); Run 2, 260 mg (88% yield, 96% ee). 
This compound was also prepared on a 5.00 mmol scale, using (3-bromo-4,4,4-
trifluorobutyl)benzene (1.34 g, 5.00 mmol) and an arylzinc chloride reagent prepared from 1-
bromo-3-methoxybenzene (0.30 M; 25 mL, 7.5 mmol; 1.5 equiv).  Following the General 
Procedure, the title compound was isolated in 91% yield (1.34 g) and 96% ee. 
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The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 0.5 mL/min); 
retention times for compound obtained using (S,S)-1: 20.4 min (minor), 32.2 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.35 – 7.27 (m, 3H), 7.24 – 7.20 (m, 1H), 7.13 – 7.10 (m, 2H), 6.93 
– 6.89 (m, 2H), 6.87 – 6.84 (m, 1H), 3.84 (s, 3H), 3.21 (dqd, 1H, J = 3.9, 9.3, 11.1 Hz), 2.61 (ddd, 1H, 
J = 4.9, 9.1, 13.9 Hz), 2.44 (ddd, 1H, J = 7.8, 8.9, 13.8 Hz), 2.34 (dddd, 1H, J = 3.9, 7.7, 9.1, 13.2 Hz), 
2.21 (dddd, 1H, J = 4.9, 9.0, 11.2, 13.8 Hz); 
13C NMR (126 MHz, CDCl3) δ 159.8, 140.6, 135.9 (d, J = 2.0 Hz), 129.7, 128.5, 128.4, 126.9 (q, J 
= 280.6 Hz), 126.2, 121.5, 115.2, 113.3, 55.2, 49.2 (q, J = 26.5 Hz), 32.5, 30.2 (d, J = 2.0 Hz); 
19F NMR (282 MHz, CDCl3) δ −69.6 (d, 3F, J = 9.3 Hz); 
FT-IR (film) 3028, 2956, 1603, 1586, 1496, 1454, 1258, 1157, 1110, 1044, 781, 700 cm-1; 
GC-MS (EI) m/z (M+) calcd for C17H17F3O: 294, found: 294; 






(R)-1-Methyl-3-(1,1,1-trifluoro-4-phenylbutan-2-yl)benzene (Table 2, Entry 3).  (3-Bromo-
4,4,4-trifluorobutyl)benzene (267 mg, 1.00 mmol) and an arylzinc chloride reagent prepared 
from 1-bromo-3-methylbenzene were used.  Solvent system for chromatography: hexane.  The 
title compound was isolated as a colorless oil. 
Run 1, 247 mg (89% yield, 95% ee); Run 2, 252 mg (91% yield, 95% ee). 
The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 0.5 mL/min); 
retention times for compound obtained using (S,S)-1: 12.4 min (minor), 13.5 min (major). 
1H NMR (500 MHz, CD3COCD3) δ 7.35 – 7.12 (m, 9H), 3.48 – 3.37 (m, 1H), 2.58 – 2.44 (m, 2H), 
2.37 (s, 3H), 2.35 – 2.21 (m, 2H); 
13C NMR (126 MHz, CD3COCD3) δ 142.0, 139.3, 135.4 (d, J = 2.1 Hz), 130.9, 129.9, 129.6, 129.4, 
129.3, 128.4 (q, J = 279.9 Hz), 127.3, 127.1, 49.8 (q, J = 26.1 Hz), 33.4, 31.1 (d, J = 2.2 Hz), 21.5; 
19F NMR (282 MHz, CD3COCD3) δ −70.2 (d, 3F, J = 9.7 Hz); 
FT-IR (film) 3028, 2955, 1496, 1454, 1259, 1171, 1147, 1110, 785, 708, 699 cm-1; 
GC-MS (EI) m/z (M+) calcd for C17H17F3: 278, found: 278; 






(R)-1-(1,1,1-Trifluoro-4-phenylbutan-2-yl)-3-(trifluoromethyl)benzene (Table 2, Entry 4).  
(3-Bromo-4,4,4-trifluorobutyl)benzene (267 mg, 1.00 mmol) and an arylzinc chloride reagent 
prepared from 1-bromo-3-(trifluoromethyl)benzene were used.  The reaction was run at −15 °C 
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for 14 h.  Solvent system for chromatography: hexane.  The title compound was isolated as a 
colorless oil. 
Run 1, 287 mg (86% yield, 96% ee); Run 2, 288 mg (87% yield, 97% ee). 
The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 0.5 mL/min); 
retention times for compound obtained using (S,S)-1: 14.6 min (minor), 17.4 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.66 – 7.63 (m, 1H), 7.56 – 7.48 (m, 3H), 7.33 – 7.27 (m, 2H), 7.26 
– 7.20 (m, 1H), 7.10 – 7.05 (m, 2H), 3.30 (dqd, 1H, J = 3.6, 9.0, 10.8 Hz), 2.65 – 2.56 (m, 1H), 2.47 – 
2.36 (m, 2H), 2.30 – 2.20 (m, 1H); 
13C NMR (126 MHz, CDCl3) δ 140.0, 135.5 (d, J = 2.2 Hz), 132.5, 131.2 (q, J = 32.5 Hz), 129.3, 
128.6, 128.3, 126.5 (q, J = 280.7 Hz), 126.4, 126.1 (q, J = 3.9 Hz), 125.2 (q, J = 3.7 Hz), 123.9 (q, J = 
271.4 Hz), 49.0 (q, J = 26.9 Hz), 32.4, 29.9 (d, J = 2.0 Hz); 
19F NMR (282 MHz, CDCl3) δ −62.7 (s, 3F), −69.7 (d, 3F, J = 9.1 Hz); 
FT-IR (film) 3029, 2958, 1497, 1454, 1332, 1258, 1169, 1115, 1077, 802, 711, 698 cm-1; 
GC-MS (EI) m/z (M+) calcd for C17H14F6: 332, found: 332; 






(R)-1-Fluoro-3-(1,1,1-trifluoro-4-phenylbutan-2-yl)benzene (Table 2, Entry 5).  (3-Bromo-
4,4,4-trifluorobutyl)benzene (267 mg, 1.00 mmol) and an arylzinc chloride reagent prepared 
from 1-bromo-3-fluorobenzene were used.  The reaction was run at −15 °C for 14 h.  Solvent 
system for chromatography: hexane.  The title compound was isolated as a colorless oil. 
Run 1, 225 mg (80% yield, 96% ee); Run 2, 220 mg (78% yield, 96% ee). 
The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 0.5 mL/min); 
retention times for compound obtained using (S,S)-1: 16.7 min (minor), 19.7 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.40 – 7.34 (m, 1H), 7.32 – 7.28 (m, 2H), 7.25 – 7.20 (m, 1H), 7.13 
– 7.01 (m, 5H), 3.29 – 3.17 (m, 1H), 2.61 (ddd, 1H, J = 4.9, 8.8, 13.5 Hz), 2.47 – 2.32 (m, 2H), 2.20 
(dddd, 1H, J = 4.9, 8.6, 11.2, 13.7 Hz); 
13C NMR (126 MHz, CDCl3) δ 162.9 (d, J = 246.6 Hz), 140.2, 136.9 (m), 130.2 (d, J = 8.3 Hz), 
128.6, 128.4, 126.6 (q, J = 280.6 Hz), 126.3, 125.1 (d, J = 2.9 Hz), 116.0 (d, J = 22.0 Hz), 115.3 (d, J = 
21.0 Hz), 48.9 (qd, J = 1.9, 26.9 Hz), 32.4, 30.1 (d, J = 2.0 Hz); 
19F NMR (282 MHz, CDCl3) δ −69.7 (d, 3F, J = 9.2 Hz), −112.4 (m, 1F); 
FT-IR (film) 3029, 2957, 1616, 1593, 1491, 1454, 1258, 1174, 1157, 1143, 1112, 787, 709, 700 cm-1; 
GC-MS (EI) m/z (M+) calcd for C16H14F4: 282, found: 282; 







(R)-1-Chloro-3-(1,1,1-trifluoro-4-phenylbutan-2-yl)benzene (Table 2, Entry 6).  (3-Bromo-
4,4,4-trifluorobutyl)benzene (267 mg, 1.00 mmol) and an arylzinc chloride reagent prepared 
from 1-bromo-3-chlorobenzene were used.  The reaction was run at −15 °C for 14 h.  Solvent 
system for chromatography: hexane.  The title compound was isolated as a colorless oil. 
Run 1, 260 mg (87% yield, 96% ee); Run 2, 255 mg (85% yield, 96% ee). 
The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 0.5 mL/min); 
retention times for compound obtained using (S,S)-1: 18.0 min (minor), 23.3 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.38 – 7.28 (m, 5H), 7.25 – 7.17 (m, 2H), 7.12 – 7.08 (m, 2H), 3.21 
(dqd, 1H, J = 3.9, 9.2, 11.0 Hz), 2.61 (ddd, 1H, J = 4.9, 8.8, 13.5 Hz), 2.47 – 2.32 (m, 2H), 2.20 
(dddd, 1H, J = 4.9, 8.5, 11.1, 13.7 Hz); 
13C NMR (126 MHz, CDCl3) δ 140.2, 136.4 (d, J = 2.0 Hz), 134.7, 130.0, 129.3, 128.6, 128.5, 
128.3, 127.4, 126.6 (q, J = 280.7 Hz), 126.4, 48.9 (q, J = 26.9 Hz), 32.4, 30.0 (d, J = 2.1 Hz); 
19F NMR (282 MHz, CDCl3) δ −69.6 (d, 3F, J = 9.1 Hz); 
FT-IR (film) 3028, 2957, 1599, 1576, 1497, 1479, 1454, 1434, 1257, 1170, 1157, 1113, 786, 713, 699 
cm-1; 
GC-MS (EI) m/z (M+) calcd for C16H14ClF3: 298, found: 298; 






(R)-(4,4,4-Trifluorobutane-1,3-diyl)dibenzene (Table 2, Entry 7).  (3-Bromo-4,4,4-
trifluorobutyl)benzene (267 mg, 1.00 mmol) and an arylzinc chloride reagent prepared from 
bromobenzene were used.  Solvent system for chromatography: hexane.  The title compound 
was isolated as a colorless oil. 
Run 1, 230 mg (87% yield, 95% ee); Run 2, 225 mg (85% yield, 95% ee). 
The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 0.5 mL/min); 
retention times for compound obtained using (S,S)-1: 15.6 min (minor), 16.6 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.44 – 7.36 (m, 3H), 7.34 – 7.28 (m, 4H), 7.25 – 7.20 (m, 1H), 7.13 
– 7.09 (m, 2H), 3.24 (dqd, 1H, J = 3.9, 9.4, 11.0 Hz), 2.61 (ddd, 1H, J = 4.9, 8.9, 13.6 Hz), 2.49 – 2.32 
(m, 2H), 2.25 (dddd, 1H, J = 4.8, 8.7, 11.1, 13.8 Hz); 
13C NMR (126 MHz, CDCl3) δ 140.6, 134.4 (d, J = 2.0 Hz), 129.2, 128.7, 128.5, 128.4, 128.2, 126.9 
(q, J = 280.6 Hz), 126.2, 49.2 (q, J = 26.5 Hz), 32.5, 30.1 (d, J = 2.0 Hz); 
19F NMR (282 MHz, CDCl3) δ −69.7 (d, 3F, J = 9.3 Hz); 
FT-IR (film) 3030, 2956, 1496, 1455, 1258, 1148, 1109, 700 cm-1; 
GC-MS (EI) m/z (M+) calcd for C16H15F3: 264, found: 264; 







(R)-1-Methyl-4-(1,1,1-trifluoro-4-phenylbutan-2-yl)benzene (Table 2, Entry 8).  (3-Bromo-
4,4,4-trifluorobutyl)benzene (267 mg, 1.00 mmol) and an arylzinc chloride reagent prepared 
from 1-bromo-4-methylbenzene were used.  Solvent system for chromatography: hexane.  The 
title compound was isolated as a colorless oil. 
Run 1, 246 mg (88% yield, 95% ee); Run 2, 250 mg (90% yield, 94% ee). 
The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 0.5 mL/min); 
retention times for compound obtained using (S,S)-1: 12.1 min (minor), 13.1 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.33 – 7.27 (m, 2H), 7.24 – 7.19 (m, 5H), 7.13 – 7.10 (m, 2H), 3.20 
(dqd, 1H, J = 3.9, 9.4, 11.2 Hz), 2.61 (ddd, 1H, J = 4.9, 9.1, 13.8 Hz), 2.47 – 2.41 (m, 1H), 2.40 (s, 
3H), 2.35 (dddd, 1H, J = 3.9, 7.7, 9.1, 13.2 Hz), 2.22 (dddd, 1H, J = 4.9, 9.0, 11.2, 13.7 Hz); 
13C NMR (126 MHz, CDCl3) δ 140.7, 138.0, 131.3 (d, J = 2.0 Hz), 129.5, 129.0, 128.5, 128.4, 127.0 
(q, J = 280.5 Hz), 126.2, 48.7 (q, J = 26.5 Hz), 32.5, 30.1 (d, J = 2.1 Hz), 21.2; 
19F NMR (282 MHz, CDCl3) δ −69.9 (d, 3F, J = 9.4 Hz); 
FT-IR (film) 3028, 2955, 1517, 1496, 1454, 1259, 1169, 1148, 1108, 814, 699 cm-1; 
GC-MS (EI) m/z (M+) calcd for C17H17F3: 278, found: 278; 






(R)-Methyl(4-(1,1,1-trifluoro-4-phenylbutan-2-yl)phenyl)sulfane (Table 2, Entry 9).  (3-
Bromo-4,4,4-trifluorobutyl)benzene (267 mg, 1.00 mmol) and an arylzinc chloride reagent 
prepared from (4-bromophenyl)(methyl)sulfane were used.  Solvent system for 
chromatography: 15:1 → 5:1 hexane/dichloromethane.  The title compound was isolated as a 
colorless oil. 
Run 1, 162 mg (52% yield, 94% ee); Run 2, 160 mg (52% yield, 93% ee). 
The ee was determined on an OD-H column (0.5% i-PrOH/hexane, flow rate 0.5 mL/min); 
retention times for compound obtained using (R,R)-1: 19.4 min (minor), 20.6 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.31 – 7.27 (m, 4H), 7.24 – 7.20 (m, 3H), 7.12 – 7.07 (m, 2H), 3.23 
– 3.14 (m, 1H), 2.60 (ddd, 1H, J = 4.9, 8.9, 13.7 Hz), 2.52 (s, 3H), 2.46 – 2.29 (m, 2H), 2.20 (dddd, 
1H, J = 4.8, 8.7, 11.2, 13.7 Hz); 
13C NMR (126 MHz, CDCl3) δ 140.5, 138.7, 131.0 (d, J = 2.3 Hz), 129.6, 128.5, 128.4, 126.8 (q, J 
= 280.6 Hz), 126.6, 126.2, 48.6 (q, J = 26.6 Hz), 32.4, 30.0 (d, J = 2.1 Hz), 15.5; 
19F NMR (282 MHz, CDCl3) δ −69.9 (d, 3F, J = 9.3 Hz); 
FT-IR (film) 3027, 2922, 1601, 1496, 1256, 1169, 1149, 1109, 816, 700 cm-1; 
 S–17 
GC-MS (EI) m/z (M+) calcd for C17H17F3S: 310, found: 310; 






(R)-1-Fluoro-4-(1,1,1-trifluoro-4-phenylbutan-2-yl)benzene (Table 2, Entry 10).  (3-Bromo-
4,4,4-trifluorobutyl)benzene (267 mg, 1.00 mmol) and an arylzinc chloride reagent prepared 
from 1-bromo-4-fluorobenzene were used.  The reaction was run at −15 °C for 14 h.  Solvent 
system for chromatography: hexane.  The title compound was isolated as a colorless oil. 
Run 1, 235 mg (83% yield, 96% ee); Run 2, 241 mg (85% yield, 96% ee). 
The ee was determined on an OD-H column (hexane, flow rate 0.5 mL/min); retention times 
for compound obtained using (R,R)-1: 26.3 min (minor), 29.8 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.32 – 7.26 (m, 4H), 7.25 – 7.20 (m, 1H), 7.13 – 7.07 (m, 4H), 3.22 
(dqd, 1H, J = 3.7, 9.2, 11.0 Hz), 2.60 (ddd, 1H, J = 4.6, 8.0, 12.2 Hz), 2.46 – 2.32 (m, 2H), 2.24 – 2.14 
(m, 1H); 
13C NMR (126 MHz, CDCl3) δ 162.6 (d, J = 247.3 Hz), 140.3, 130.8 (d, J = 8.0 Hz), 130.1 (d, J = 
1.7 Hz), 128.5, 128.4, 126.7 (q, J = 280.4 Hz), 126.3, 115.7 (d, J = 21.5 Hz), 48.4 (q, J = 26.8 Hz), 32.4, 
30.1 (d, J = 2.1 Hz); 
19F NMR (282 MHz, CDCl3) δ −70.0 (d, 3F, J = 9.2 Hz), −113.9 (m, 1F); 
FT-IR (film) 3028, 2956, 1609, 1513, 1497, 1455, 1258, 1230, 1163, 1111, 831, 699 cm-1; 
GC-MS (EI) m/z (M+) calcd for C16H14F4: 282, found: 282; 






(R)-1-Bromo-4-(1,1,1-trifluoro-4-phenylbutan-2-yl)benzene (Table 2, Entry 11).  (3-Bromo-
4,4,4-trifluorobutyl)benzene (267 mg, 1.00 mmol) and an arylzinc chloride reagent prepared 
from 1,4-dibromobenzene were used.  The reaction was run at −15 °C for 14 h.  Solvent 
system for chromatography: hexane.  The title compound was isolated as a colorless oil. 
Run 1, 296 mg (86% yield, 95% ee); Run 2, 300 mg (87% yield, 95% ee). 
The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 0.5 mL/min); 
retention times for compound obtained using (S,S)-1: 20.0 min (minor), 22.6 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.56 – 7.52 (m, 2H), 7.32 – 7.27 (m, 2H), 7.25 – 7.16 (m, 3H), 7.10 
– 7.07 (m, 2H), 3.20 (dqd, 1H, J = 3.8, 9.2, 10.9 Hz), 2.60 (ddd, 1H, J = 4.5, 7.8, 11.8 Hz), 2.46 – 2.31 
(m, 2H), 2.24 – 2.13 (m, 1H); 
 S–18 
13C NMR (126 MHz, CDCl3) δ 140.2, 133.4 (d, J = 1.9 Hz), 132.0, 130.8, 128.6, 128.3, 126.5 (q, J 
= 280.6 Hz), 126.3, 122.4, 48.6 (q, J = 26.7 Hz), 32.3, 29.9 (d, J = 2.0 Hz); 
19F NMR (282 MHz, CDCl3) δ −69.8 (d, 3F, J = 9.3 Hz); 
FT-IR (film) 3028, 2956, 1491, 1454, 1256, 1170, 1156, 1114, 1076, 1012, 819, 699 cm-1; 
GC-MS (EI) m/z (M+) calcd for C16H1479BrF3: 342, found: 342, 344 (M++2); 






(R)-5-(1,1,1-Trifluoro-4-phenylbutan-2-yl)benzofuran (Table 2, Entry 12).  (3-Bromo-4,4,4-
trifluorobutyl)benzene (267 mg, 1.00 mmol) and an arylzinc chloride reagent prepared from 5-
bromobenzofuran were used.  Solvent system for chromatography: 20:1 
hexane/dichloromethane.  The title compound was isolated as a colorless oil. 
Run 1, 184 mg (61% yield, 94% ee); Run 2, 178 mg (59% yield, 94% ee). 
The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 0.5 mL/min); 
retention times for compound obtained using (S,S)-1: 21.8 min (minor), 22.6 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.67 (d, 1H, J = 2.2 Hz), 7.57 – 7.53 (m, 2H), 7.32 – 7.28 (m, 2H), 
7.26 – 7.20 (m, 2H), 7.13 – 7.09 (m, 2H), 6.80 (dd, 1H, J = 1.0, 2.2 Hz), 3.35 (dqd, 1H, J = 3.7, 9.3, 
11.1 Hz), 2.66 – 2.57 (m, 1H), 2.50 – 2.38 (m, 2H), 2.34 – 2.24 (m, 1H); 
13C NMR (126 MHz, CDCl3) δ 154.7, 145.7, 140.6, 128.8 (q, J = 2.1 Hz), 128.5, 128.4, 127.8, 127.0 
(q, J = 280.7 Hz), 126.2, 125.3, 121.8, 111.6, 106.6, 49.0 (q, J = 26.6 Hz), 32.5, 30.4 (d, J = 2.0 Hz); 
19F NMR (282 MHz, CDCl3) δ −69.8 (d, 3F, J = 9.4 Hz); 
FT-IR (film) 3028, 2955, 1471, 1454, 1259, 1157, 1127, 1107, 1031, 742, 699 cm-1; 
GC-MS (EI) m/z (M+) calcd for C18H15F3O: 304, found: 304; 







(R)-1-Methyl-5-(1,1,1-trifluoro-4-phenylbutan-2-yl)-1H-indole (Table 2, Entry 13).  (3-
Bromo-4,4,4-trifluorobutyl)benzene (267 mg, 1.00 mmol) and an arylzinc chloride reagent 
prepared from 5-bromo-1-methyl-1H-indole were used.  Solvent system for chromatography: 
20:1 → 12:1 hexane/dichloromethane.  The title compound was isolated as a light-green color 
solid. 
Run 1, 209 mg (66% yield, 94% ee); Run 2, 222 mg (70% yield, 94% ee). 
 S–19 
The ee was determined on an OD-H column (0.5% i-PrOH/hexane, flow rate 0.5 mL/min); 
retention times for compound obtained using (R,R)-1: 23.0 min (major), 24.8 min (minor). 
1H NMR (500 MHz, CDCl3) δ 7.61 – 7.59 (m, 1H), 7.37 (d, 1H J = 8.4 Hz), 7.33 – 7.29 (m, 2H), 
7.25 – 7.18 (m, 2H), 7.15 – 7.10 (m, 3H), 6.54 (dd, 1H, J = 0.9, 3.1 Hz), 3.83 (s, 3H), 3.35 (dqd, 1H, J 
= 3.6, 9.3, 11.0 Hz), 2.66 – 2.60 (m, 1H), 2.51 – 2.29 (m, 3H); 
13C NMR (126 MHz, CDCl3) δ 141.0, 136.5, 129.5, 128.6, 128.43, 128.40, 127.3 (q, J = 280.5 Hz), 
126.1, 125.0 (q, J = 2.0 Hz), 122.4, 121.7, 109.4, 101.0, 49.2 (q, J = 26.3 Hz), 32.9, 32.5, 30.5 (d, J = 2.0 
Hz); 
19F NMR (282 MHz, CDCl3) δ −69.8 (d, 3F, J = 9.4 Hz); 
FT-IR (film) 3027, 2951, 1514, 1495, 1453, 1336, 1258, 1138, 1103, 799, 724, 700 cm-1; 
GC-MS (EI) m/z (M+) calcd for C19H18F3N: 317, found: 317; 






(R)-4-(1,1,1-Trifluoro-4-phenylbutan-2-yl)-1,1'-biphenyl (for determination of absolute 
stereochemistry).  (3-Bromo-4,4,4-trifluorobutyl)benzene (267 mg, 1.00 mmol) and an arylzinc 
chloride reagent prepared from 4-bromo-1,1'-biphenyl were used.  Solvent system for 
chromatography: hexane → 10:1 hexane/dichloromethane.  The title compound was isolated 
as a white solid. 
Run 1, 160 mg (47% yield, 94% ee); Run 2, 158 mg (46% yield, 93% ee). 
The ee was determined on an OD-H column (1.0% i-PrOH/hexane, flow rate 1.0 mL/min); 
retention times for compound obtained using (R,R)-1: 7.0 min (minor), 11.1 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.65 – 7.62 (m, 4H), 7.50 – 7.45 (m, 2H), 7.42 – 7.36 (m, 3H), 7.33 
– 7.29 (m, 2H), 7.25 – 7.20 (m, 1H), 7.15 – 7.11 (m, 2H), 3.29 (dqd, 1H, J = 3.9, 9.3, 11.0 Hz), 2.65 
(ddd, 1H, J = 4.9, 9.0, 13.8 Hz), 2.53 – 2.35 (m, 2H), 2.27 (dddd, 1H, J = 4.9, 8.8, 11.1, 13.8 Hz); 
13C NMR (126 MHz, CDCl3) δ 141.1, 140.6, 140.5, 133.4 (d, J = 2.0 Hz), 129.6, 128.8, 128.5, 
128.4, 127.5, 127.4, 127.1, 126.9 (q, J = 280.6 Hz), 126.2, 48.8 (q, J = 26.5 Hz), 32.5, 30.1 (d, J = 2.0 
Hz); 
19F NMR (282 MHz, CDCl3) δ −69.6 (d, 3F, J = 9.3 Hz); 
FT-IR (film) 3061, 3030, 2955, 1496, 1487, 1454, 1256, 1168, 1148, 1108, 1009, 833, 765, 737, 698 
cm-1; 
GC-MS (EI) m/z (M+) calcd for C22H19F3: 340, found: 340; 







(R)-1-Methoxy-3-(1,1,1-trifluoropropan-2-yl)benzene (Table 3, Entry 1).  2-Bromo-1,1,1-
trifluoropropane (177 mg, 1.00 mmol) and an arylzinc chloride reagent prepared from 1-bromo-
3-methoxybenzene were used.  Solvent system for chromatography: 15:1 
hexane/dichloromethane.  The title compound was isolated as a colorless oil. 
Run 1, 166 mg (81% yield, 92% ee); Run 2, 164 mg (80% yield, 90% ee). 
The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 0.5 mL/min); 
retention times for compound obtained using (S,S)-1: 19.5 min (minor), 29.0 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.30 – 7.26 (m, 1H), 6.93 – 6.91 (m, 1H), 6.89 – 6.87 (m, 2H), 3.82 
(s, 3H), 3.40 (qq, 1H, J = 7.2, 9.2 Hz), 1.51 (d, 3H, J = 7.3 Hz); 
13C NMR (126 MHz, CDCl3) δ 159.6, 137.9, 129.5, 127.1 (q, J = 280.5 Hz), 120.8, 114.6, 113.1, 
55.2, 44.2 (q, J = 27.5 Hz), 14.6 (d, J = 2.8 Hz); 
19F NMR (282 MHz, CDCl3) δ −71.4 (d, 3F, J = 9.3 Hz); 
FT-IR (film) 2992, 2948, 2839, 1604, 1588, 1496, 1465, 1291, 1261, 1237, 1172, 1126, 1041, 991, 
781, 703 cm-1; 
GC-MS (EI) m/z (M+) calcd for C10H11F3O: 204, found: 204; 






(R)-1-Methoxy-3-(1,1,1-trifluorodecan-2-yl)benzene (Table 3, Entry 2).  2-Bromo-1,1,1-
trifluorodecane (275 mg, 1.00 mmol) and an arylzinc chloride reagent prepared from 1-bromo-3-
methoxybenzene were used.  Solvent system for chromatography: 15:1 
hexane/dichloromethane.  The title compound was isolated as a colorless oil. 
Run 1, 265 mg (88% yield, 94% ee); Run 2, 263 mg (87% yield, 96% ee). 
The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 0.5 mL/min); 
retention times for compound obtained using (S,S)-1: 10.8 min (minor), 15.5 min (major). 
1H NMR (500 MHz, CD3CN) δ 7.31 – 7.27 (m, 1H), 6.93 – 6.87 (m, 3H), 3.78 (s, 3H), 3.43 – 3.32 
(m, 1H), 1.99 – 1.84 (m, 2H), 1.35 – 1.06 (m, 12H), 0.86 (t, 3H, J = 7.0 Hz); 
13C NMR (126 MHz, CD3CN) δ 160.9, 137.6 (d, J = 2.1 Hz), 130.7, 128.5 (q, J = 279.2 Hz), 122.3, 
116.1, 114.2, 56.0, 50.2 (q, J = 25.9 Hz), 32.6, 30.0, 29.9, 29.8, 29.1 (q, J = 2.3 Hz), 27.3, 23.4, 14.4; 
19F NMR (282 MHz, CD3CN) δ −70.3 (d, 3F, J = 9.7 Hz); 
FT-IR (film) 2926, 2856, 1603, 1587, 1496, 1456, 1436, 1259, 1161, 1125, 1104, 1047, 708 cm-1; 
GC-MS (EI) m/z (M+) calcd for C17H25F3O: 302, found: 302; 







(R)-1-(3-Cyclohexyl-1,1,1-trifluoropropan-2-yl)-3-methoxybenzene (Table 3, Entry 3).  (2-
Bromo-3,3,3-trifluoropropyl)cyclohexane (259 mg, 1.00 mmol) and an arylzinc chloride reagent 
prepared from 1-bromo-3-methoxybenzene were used.  Solvent system for chromatography: 
25:1 hexane/dichloromethane.  The title compound was isolated as a colorless oil. 
Run 1, 230 mg (80% yield, 96% ee); Run 2, 231 mg (81% yield, 96% ee). 
The ee was determined on an OJ-H column (0.25% i-PrOH/hexane, flow rate 0.5 mL/min); 
retention times for compound obtained using (R,R)-1: 9.1 min (minor), 9.7 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.30 – 7.25 (m, 1H), 6.90 – 6.81 (m, 3H), 3.82 (s, 3H), 3.33 (dqd, 
1H, J = 4.0, 9.4, 11.2 Hz), 1.86 – 1.71 (m, 3H), 1.68 – 1.54 (m, 4H), 1.18 – 1.02 (m, 4H), 1.00 – 0.82 
(m, 2H); 
13C NMR (126 MHz, CDCl3) δ 159.6, 136.6 (d, J = 2.0 Hz), 129.5, 127.2 (q, J = 280.5 Hz), 121.5, 
115.2, 112.9, 55.2, 47.2 (q, J = 26.2 Hz), 36.0 (d, J = 2.0 Hz), 34.2, 33.9, 31.8, 26.4, 26.0, 25.8; 
19F NMR (282 MHz, CDCl3) δ −69.8 (d, 3F, J = 9.4 Hz); 
FT-IR (film) 2926, 2852, 1604, 1587, 1490, 1452, 1261, 1183, 1155, 1113, 1050, 779, 710 cm-1; 
GC-MS (EI) m/z (M+) calcd for C16H21F3O: 286, found: 286; 






(R)-tert-Butyldiphenyl((7,7,7-trifluoro-6-(3-methoxyphenyl)heptyl)oxy)silane (Table 3, 
Entry 4).  ((6-Bromo-7,7,7-trifluoroheptyl)oxy)(tert-butyl)diphenylsilane (487 mg, 1.00 mmol) 
and an arylzinc chloride reagent prepared from 1-bromo-3-methoxybenzene were used.  
Solvent system for chromatography: 4:1 hexane/dichloromethane.  The title compound was 
isolated as a colorless oil. 
Run 1, 390 mg (76% yield, 94% ee); Run 2, 395 mg (77% yield, 94% ee). 
The ee was determined on an OD-H column (1.0% i-PrOH/hexane, flow rate 1.0 mL/min); 
retention times for compound obtained using (S,S)-1: 4.7 min (minor), 7.8 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.69 – 7.64 (m, 4H), 7.46 – 7.35 (m, 6H), 7.30 – 7.23 (m, 1H), 6.90 
– 6.81 (m, 3H), 3.82 (s, 3H), 3.65 – 3.59 (m, 2H), 3.17 (dqd, 1H, J = 4.0, 9.3, 11.0 Hz), 2.03 – 1.92 (m, 
1H), 1.90 – 1.79 (m, 1H), 1.57 – 1.27 (m, 4H), 1.23 – 1.14 (m, 2H), 1.06 (s, 9H); 
13C NMR (126 MHz, CDCl3) δ 159.7, 136.4 (d, J = 2.0 Hz), 135.5, 134.0 (d, J = 1.4 Hz), 129.6, 
129.5, 127.6, 126.9 (q, J = 280.7 Hz), 121.4, 115.0, 113.0, 63.7, 55.2, 50.0 (q, J = 26.3 Hz), 32.2, 28.7 
(d, J = 2.2 Hz), 26.9, 26.5, 25.5, 19.2; 
19F NMR (282 MHz, CDCl3) δ −69.6 (d, 3F, J = 9.3 Hz); 
FT-IR (film) 2933, 2858, 1603, 1587, 1490, 1472, 1428, 1260, 1161, 1113, 702 cm-1; 
GC-MS (EI) m/z (M+−C4H9) calcd for C26H28F3O2Si: 457, found: 457; 
 S–22 






(R)-1-(6-Chloro-1,1,1-trifluorohexan-2-yl)-3-methoxybenzene (Table 3, Entry 5).  2-Bromo-
6-chloro-1,1,1-trifluorohexane (253 mg, 1.00 mmol) and an arylzinc chloride reagent prepared 
from 1-bromo-3-methoxybenzene were used.  Solvent system for chromatography: 15:1 → 12:1 
→ 10:1 hexane/dichloromethane.  The title compound was isolated as a colorless oil. 
Run 1, 250 mg (89% yield, 96% ee); Run 2, 248 mg (88% yield, 96% ee). 
The ee was determined on an OJ-H column (0.25% i-PrOH/hexane, flow rate 0.5 mL/min); 
retention times for compound obtained using (R,R)-1: 26.1 min (minor), 27.5 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.30 – 7.26 (m, 1H), 6.89 – 6.86 (m, 2H), 6.83 – 6.82 (m, 1H), 3.82 
(s, 3H), 3.52 – 3.42 (m, 2H), 3.19 (dqd, 1H, J = 4.1, 9.2 ,11.0 Hz), 2.05 – 1.96 (m, 1H), 1.94 – 1.68 (m, 
3H), 1.43 – 1.28 (m, 2H); 
13C NMR (126 MHz, CDCl3) δ 159.7, 136.0 (d, J = 2.3 Hz), 129.7, 126.8 (q, J = 280.7 Hz), 121.3, 
115.0, 113.2, 55.2, 50.0 (q, J = 26.6 Hz), 44.4, 32.1, 28.1 (d, J = 2.2 Hz), 24.1; 
19F NMR (282 MHz, CDCl3) δ −69.7 (d, 3F, J = 9.3 Hz); 
FT-IR (film) 2954, 1603, 1490, 1456, 1257, 1159, 1109, 1043, 781, 707 cm-1; 
GC-MS (EI) m/z (M+) calcd for C13H16ClF3O: 280, found: 280; 






(R)-1-(10-Bromo-1,1,1-trifluorodecan-2-yl)-3-methoxybenzene (Table 3, Entry 6).  2,10-
Dibromo-1,1,1-trifluorodecane (354 mg, 1.00 mmol) and an arylzinc chloride reagent prepared 
from 1-bromo-3-methoxybenzene were used.  Solvent system for chromatography: 15:1 → 12:1 
→ 10:1 hexane/dichloromethane.  The title compound was isolated as a colorless oil. 
Run 1, 309 mg (81% yield, 96% ee); Run 2, 300 mg (79% yield, 95% ee). 
The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 1.0 mL/min); 
retention times for compound obtained using (S,S)-1: 14.9 min (minor), 25.4 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.31 – 7.25 (m, 1H), 6.88 – 6.86 (m, 2H), 6.83 – 6.82 (m, 1H), 3.82 
(s, 3H), 3.39 (t, 2H, J = 6.8 Hz), 3.18 (dqd, 1H, J = 4.0, 9.3, 11.1 Hz), 1.97 (dddd, 1H, J = 4.1, 7.7, 
9.2, 13.4 Hz), 1.89 – 1.78 (m, 3H), 1.45 – 1.13 (m, 10H); 
13C NMR (126 MHz, CDCl3) δ 159.6, 136.5 (d, J = 2.2 Hz), 129.5, 126.9 (q, J = 280.7 Hz), 121.4, 
115.1, 113.0, 55.2, 50.1 (q, J = 26.3 Hz), 33.9, 32.7, 29.1, 29.0, 28.64 (d, J = 2.0 Hz), 28.57, 28.0, 26.6; 
19F NMR (282 MHz, CDCl3) δ −69.7 (d, 3F, J = 9.3 Hz); 
FT-IR (film) 2929, 2856, 1603, 1490, 1457, 1437, 1257, 1158, 1109, 1050, 780, 708 cm-1; 
 S–23 
GC-MS (EI) m/z (M+) calcd for C17H2479BrF3O: 380, found: 380, 382 (M++2); 






(R)-7,7,7-Trifluoro-6-(3-methoxyphenyl)heptyl 4-methylbenzenesulfonate (Table 3, Entry 
7).  6-Bromo-7,7,7-trifluoroheptyl 4-methylbenzenesulfonate (403 mg, 1.00 mmol) and an 
arylzinc chloride reagent prepared from 1-bromo-3-methoxybenzene were used.  Solvent 
system for chromatography: 1:1 → 1:1.5 → 1:2 hexane/dichloromethane.  The title compound 
was isolated as a colorless oil. 
Run 1, 391 mg (91% yield, 97% ee); Run 2, 393 mg (91% yield, 97% ee). 
The ee was determined on an OJ-H column (10% i-PrOH/hexane, flow rate 1.0 mL/min); 
retention times for compound obtained using (R,R)-1: 32.0 min (minor), 34.7 min (major). 
1H NMR (500 MHz, CD3COCD3) δ 7.80 – 7.76 (m, 2H), 7.48 – 7.44 (m, 2H), 7.33 – 7.28 (m, 1H), 
6.95 – 6.90 (m, 3H), 3.99 (td, 2H, J = 1.1, 6.4 Hz), 3.80 (s, 3H), 3.46 – 3.37 (m, 1H), 2.45 (s, 3H), 1.96 
– 1.83 (m, 2H), 1.63 – 1.50 (m, 2H), 1.40 – 1.06 (m, 4H); 
13C NMR (126 MHz, CD3COCD3) δ 160.9, 145.8, 137.3 (d, J = 2.1 Hz), 134.5, 130.9, 130.6, 128.7, 
128.3 (q, J = 279.9 Hz), 122.1, 116.1, 114.1, 71.4, 55.6, 50.2 (q, J = 26.1 Hz), 29.2, 29.0 (d, J = 2.2 Hz), 
26.8, 25.7, 21.6; 
19F NMR (282 MHz, CD3COCD3) δ −70.2 (d, 3F, J = 9.6 Hz); 
FT-IR (film) 2945, 1600, 1496, 1457, 1358, 1258, 1176, 1118, 956, 815, 708, 663 cm-1; 
GC-MS (EI) m/z (M+−OTs) calcd for C14H18F3O: 259, found: 259; 









(R)-1-(4-((7,7,7-Trifluoro-6-(3-methoxyphenyl)heptyl)oxy)phenyl)ethan-1-one (Table 3, 
Entry 8).  1-(4-((6-Bromo-7,7,7-trifluoroheptyl)oxy)phenyl)ethan-1-one (367 mg, 1.00 mmol) 
and an arylzinc chloride reagent prepared from 1-bromo-3-methoxybenzene were used.  
Solvent system for chromatography: 15:1 → 10:1 hexane/dichloromethane.  The title 
compound was isolated as a colorless oil. 
Run 1, 357 mg (91% yield, 95% ee); Run 2, 342 mg (87% yield, 96% ee). 
The ee was determined on an AD-H column (5% i-PrOH/hexane, flow rate 1.0 mL/min); 
retention times for compound obtained using (R,R)-1: 14.4 min (minor), 17.4 min (major). 
 S–24 
1H NMR (500 MHz, CDCl3) δ 7.93 – 7.89 (m, 2H), 7.28 – 7.25 (m, 1H), 6.89 – 6.82 (m, 5H), 3.97 
– 3.94 (m, 2H), 3.81 (s, 3H), 3.19 (dqd, 1H, J = 4.1, 9.3, 11.0 Hz), 2.55 (s, 3H), 2.05 – 1.97 (m, 1H), 
1.92 – 1.84 (m, 1H), 1.79 – 1.69 (m, 2H), 1.54 – 1.38 (m, 2H), 1.31 – 1.23 (m, 2H); 
13C NMR (126 MHz, CDCl3) δ 196.7, 162.9, 159.7, 136.3 (d, J = 2.0 Hz), 130.5, 130.2, 129.6, 126.9 
(q, J = 280.6 Hz), 121.3, 115.1, 114.1, 113.0, 67.9, 55.2, 50.0 (q, J = 26.4 Hz), 28.7, 28.6 (d, J = 2.2 Hz), 
26.4, 26.3, 25.7; 
19F NMR (282 MHz, CDCl3) δ −69.7 (d, 3F, J = 9.3 Hz); 
FT-IR (film) 2943, 1675, 1601, 1255, 1170, 1117, 834, 708 cm-1; 
GC-MS (EI) m/z (M+) calcd for C22H25F3O3: 394, found: 394; 








(R)-1-Methoxy-3-(1,1,1-trifluoro-7-(4-iodophenoxy)heptan-2-yl)benzene (Table 3, Entry 9).  
1-((6-Bromo-7,7,7-trifluoroheptyl)oxy)-4-iodobenzene (451 mg, 1.00 mmol) and an arylzinc 
chloride reagent prepared from 1-bromo-3-methoxybenzene were used.  Solvent system for 
chromatography: 10:1 → 5:1 → 4:1 hexane/dichloromethane.  The title compound was isolated 
as a colorless oil. 
Run 1, 282 mg (59% yield, 95% ee); Run 2, 292 mg (61% yield, 95% ee). 
The ee was determined on an OD-H column (10% i-PrOH/hexane, flow rate 1.0 mL/min); 
retention times for compound obtained using (R,R)-1: 12.6 min (minor), 22.9 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.56 – 7.51 (m, 2H), 7.30 – 7.24 (m, 1H), 6.90 – 6.81 (m, 3H), 6.66 
– 6.61 (m, 2H), 3.85 (t, 2H, J = 6.4 Hz), 3.81 (s, 3H), 3.19 (dqd, 1H, J = 4.1, 9.3, 11.0 Hz), 2.07 – 1.96 
(m, 1H), 1.93 – 1.83 (m, 1H), 1.78 – 1.63 (m, 2H), 1.54 – 1.36 (m, 2H), 1.32 – 1.19 (m, 2H); 
13C NMR (126 MHz, CDCl3) δ 159.7, 158.8, 138.1, 136.3 (d, J = 2.1 Hz), 129.6, 126.9 (q, J = 280.7 
Hz), 121.3, 116.9, 115.1, 113.0, 82.5, 67.7, 55.2, 50.0 (q, J = 26.4 Hz), 28.8, 28.6 (d, J = 2.1 Hz), 26.4, 
25.7; 
19F NMR (282 MHz, CDCl3) δ −69.7 (d, 3F, J = 9.3 Hz); 
FT-IR (film) 2942, 1586, 1486, 1472, 1244, 1174, 1118, 820, 708 cm-1; 
GC-MS (EI) m/z (M+) calcd for C20H22F3IO2: 478, found: 478; 









(Table 3, Entry 10).  tert-Butyl 4-(2-bromo-3,3,3-trifluoropropyl)piperidine-1-carboxylate (360 
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mg, 1.00 mmol) and an arylzinc chloride reagent prepared from 1-bromo-3-methoxybenzene 
were used.  Solvent system for chromatography: 15:1 → 10:1 hexane/dichloromethane.  The 
title compound was isolated as a light-yello solid. 
Run 1, 320 mg (83% yield, 96% ee); Run 2, 315 mg (81% yield, 97% ee). 
The ee was determined on an OJ-H column (2.0% i-PrOH/hexane, flow rate 1.0 mL/min); 
retention times for compound obtained using (S,S)-1: 8.5 min (minor), 13.0 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.29 – 7.25 (m, 1H), 6.89 – 6.81 (m, 3H), 4.02 (br, 2H), 3.81 (s, 
3H), 3.36 – 3.27 (m, 1H), 2.54 (br, 2H), 1.90 (ddd, 1H, J = 4.4, 11.4, 13.8 Hz), 1.78 (ddd, 1H, J = 4.0, 
9.4, 13.7 Hz), 1.68 – 1.64 (m, 1H), 1.52 – 1.48 (m, 1H), 1.43 (s, 9H), 1.27 – 1.04 (m, 3H); 
13C NMR (126 MHz, CDCl3) δ 159.7, 154.7, 136.0 (d, J = 1.9 Hz), 129.7, 126.9 (q, J = 280.7 Hz), 
121.3, 115.1, 113.0, 79.3, 55.2, 47.1 (q, J = 26.5 Hz), 35.2 (d, J = 1.9 Hz), 32.7, 32.5, 30.8, 28.4; 
19F NMR (282 MHz, CDCl3) δ −69.9 (d, 3F, J = 9.2 Hz); 
FT-IR (film) 2932, 1690, 1456, 1424, 1366, 1259, 1162, 1118, 1098, 969, 711 cm-1; 
GC-MS (EI) m/z (M+–Boc) calcd for C15H19F3NO: 286, found: 286; 









(R)-7,7,7-Trifluoro-6-(3-methoxyphenyl)heptyl furan-2-carboxylate (Table 3, Entry 11).  6-
Bromo-7,7,7-trifluoroheptyl furan-2-carboxylate (343 mg, 1.00 mmol) and an arylzinc chloride 
reagent prepared from 1-bromo-3-methoxybenzene were used.  Solvent system for 
chromatography: 1:1 → 1:1.2 → 1:1.5 hexane/dichloromethane.  The title compound was 
isolated as a yellow oil. 
Run 1, 298 mg (81% yield, 96% ee); Run 2, 298 mg (81% yield, 96% ee). 
The ee was determined on an OJ-H column (5% i-PrOH/hexane, flow rate 1.0 mL/min); 
retention times for compound obtained using (R,R)-1: 25.6 min (minor), 33.0 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.57 (dd, 1H, J = 0.9, 1.8 Hz), 7.29 – 7.24 (m, 1H), 7.14 (dd, 1H, J 
= 0.8, 3.5 Hz), 6.89 – 6.80 (m, 3H), 6.50 (dd, 1H, J = 1.7, 3.5 Hz), 4.24 (t, 2H, J = 6.6 Hz), 3.80 (s, 
3H), 3.18 (dqd, 1H, J = 4.1, 9.3, 11.0 Hz), 1.99 (dddd, 1H, J = 4.1, 7.1, 9.7, 13.7 Hz), 1.91 – 1.81 (m, 
1H), 1.76 – 1.61 (m, 2H), 1.50 – 1.32 (m, 2H), 1.29 – 1.21 (m, 2H); 
13C NMR (126 MHz, CDCl3) δ 159.7, 158.7, 146.2, 144.7, 136.3 (d, J = 2.2 Hz), 129.6, 126.9 (q, J 
= 280.6 Hz), 121.3, 117.7, 115.0, 113.0, 111.8, 64.7, 55.2, 50.0 (q, J = 26.4 Hz), 28.6 (d, J = 2.0 Hz), 
28.4, 26.4, 25.6; 
19F NMR (282 MHz, CDCl3) δ −69.7 (d, 3F, J = 9.2 Hz); 
FT-IR (film) 2947, 1727, 1603, 1584, 1473, 1297, 1259, 1180, 1119, 765, 709 cm-1; 
GC-MS (EI) m/z (M+) calcd for C19H21F3O4: 370, found: 370; 







(R)-1-Methoxy-3-(1,1,1-trifluoro-4-phenylbutan-2-yl)benzene (eq 3).  (4,4,4-Trifluoro-3-
iodobutyl)benzene (314 mg, 1.00 mmol) and an arylzinc chloride reagent prepared from 1-
bromo-3-methoxybenzene were used. Solvent system for chromatography: 5:1 → 4:1 
hexane/dichloromethane.  The title compound was isolated as a colorless oil. 
Run 1, 277 mg (94% yield, 96% ee); Run 2, 277 mg (94% yield, 96% ee). 
The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 0.5 ml/min); 
retention times for compound obtained using (S,S)-1: 20.2 min (minor), 32.3 min (major). 







(R)-1-(4,4,5,5,6,6,6-Heptafluoro-1-phenylhexan-3-yl)-3-methoxybenzene (eq 4).  (3-Bromo-
4,4,5,5,6,6,6-heptafluorohexyl)benzene (367 mg, 1.00 mmol) and an arylzinc chloride reagent 
prepared from 1-bromo-3-methoxybenzene were used.  Solvent system for chromatography: 
15:1 → 12:1 → 10:1 hexane/dichloromethane.  The title compound was isolated as a colorless 
oil. 
Run 1, 363 mg (92% yield, 99% ee); Run 2, 361 mg (92% yield, 99% ee). 
The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 0.5 mL/min); 
retention times for compound obtained using (S,S)-1: 12.8 min (minor), 15.6 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.34 – 7.28 (m, 3H), 7.24 – 7.20 (m, 1H), 7.11 – 7.09 (m, 2H), 6.93 
– 6.90 (m, 2H), 6.86 – 6.85 (m, 1H), 3.84 (s, 3H), 3.34 – 3.25 (m, 1H), 2.60 – 2.53 (m, 1H), 2.45 – 2.34 
(m, 2H), 2.26 – 2.17 (m, 1H); 
13C NMR (126 MHz, CDCl3) δ 159.7, 140.5, 135.5 (d, J = 5.4 Hz), 129.6, 128.5, 128.4, 126.2, 
122.0, 119.5 – 115.2 (m), 115.6, 113.2, 112.1 – 107.0 (m), 55.2, 47.1 (t, J = 21.0 Hz), 32.4, 29.3; 
19F NMR (282 MHz, CDCl3) δ −80.7 (dd, 3F, J = 10.2, 11.9 Hz), −112.9 – −116.8 (m, 2F), −122.6 
– −125.6 (m, 2F); 
FT-IR (film) 2961, 1603, 1587, 1496, 1456, 1348, 1219, 1174, 1116, 1045, 933, 728, 698 cm-1; 
GC-MS (EI) m/z (M+) calcd for C19H17F7O: 394, found: 394; 







(R)-1-(1-Chloro-1,1-difluoro-4-phenylbutan-2-yl)-4-methoxybenzene (eq 5).  (3-Bromo-4-
chloro-4,4-difluorobutyl)benzene (283 mg, 1.00 mmol) and an arylzinc chloride reagent 
prepared from 1-bromo-4-methoxybenzene were used.  Solvent system for chromatography: 
6:1 → 4:1 hexane/dichloromethane.  The title compound was isolated as a colorless oil. 
Run 1, 274 mg (88% yield, 96% ee); Run 2, 278 mg (89% yield, 96% ee). 
The ee was determined on an OD-H column (0.25% i-PrOH/hexane, flow rate 0.5 mL/min); 
retention times for compound obtained using (R,R)-1: 29.1 min (minor), 34.4 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.31 – 7.19 (m, 5H), 7.11 – 7.08 (m, 2H), 6.96 – 6.92 (m, 2H), 3.85 
(s, 3H), 3.30 (qd, 1H, J = 3.1, 11.5 Hz), 2.63 – 2.57 (m, 1H), 2.45 – 2.36 (m, 2H), 2.27 – 2.19 (m, 1H); 
13C NMR (126 MHz, CDCl3) δ 159.5, 140.7, 131.2 (t, J = 296.2 Hz), 130.6, 128.5, 128.4, 126.8 (t, J 
= 2.5 Hz), 126.2, 114.0, 55.2, 54.8 (t, J = 22.3 Hz), 32.6, 30.8 (t, J = 2.2 Hz); 
19F NMR (282 MHz, CDCl3) δ −53.9 (dd, 1F, J = 10.9, 160.5 Hz), −54.7 (dd, 1F, J = 11.9, 160.7 
Hz); 
FT-IR (film) 3026, 2956, 1612, 1515, 1496, 1454, 1306, 1251, 1180, 1114, 1034, 947, 826, 699 cm-1; 
GC-MS (EI) m/z (M+) calcd for C17H17ClF2O: 310, found: 310; 








(R)-2,2-Difluoro-1,3,5-triphenylpentan-1-one (eq 6).  3-Bromo-2,2-difluoro-1,5-
diphenylpentan-1-one (353 mg, 1.00 mmol) and an arylzinc chloride reagent prepared from 
bromobenzene were used.  Solvent system for chromatography: 10:1 → 5:1 → 2:1 
hexane/dichloromethane.  The title compound was isolated as a white solid. 
Run 1, 283 mg (81% yield, 98% ee); Run 2, 280 mg (80% yield, 97% ee). 
The ee was determined on an AD-H column (0.25% i-PrOH/hexane, flow rate 0.5 mL/min); 
retention times for compound obtained using (R,R)-1: 20.1 min (minor), 20.9 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.88 – 7.85 (m, 2H), 7.59 – 7.55 (m, 1H), 7.43 – 7.39 (m, 2H), 7.35 
– 7.24 (m, 7H), 7.20 – 7.17 (m, 1H), 7.10 – 7.07 (m, 2H), 3.62 – 3.52 (m, 1H), 2.58 (ddd, 1H, J = 4.7, 
9.3, 13.6 Hz), 2.46 – 2.33 (m, 2H), 2.29 – 2.22 (m, 1H); 
13C NMR (126 MHz, CDCl3) δ 190.1 (t, J = 30.0 Hz), 141.0, 135.02, 134.98, 133.9, 132.8, 129.84, 
129.79 (t, J = 3.5 Hz), 128.6, 128.5, 128.4, 127.9, 126.0, 119.4 (t, J = 258.1 Hz), 49.2 (t, J = 21.5 Hz), 
32.8, 29.6 (t, J = 3.6 Hz); 
19F NMR (282 MHz, CDCl3) δ −103.1 (dd, 1F, J = 15.4, 272.5 Hz), −105.4 (dd, 1F, J = 17.3, 272.5 
Hz); 
FT-IR (film) 3028, 1701, 1598, 1496, 1454, 1161, 1089, 1065, 912, 698 cm-1; 
GC-MS (EI) m/z (M+) calcd for C23H20F2O: 350, found: 350; 









Ethyl (R)-2,2-difluoro-3-(3-methoxyphenyl)-5-phenylpentanoate (eq 7).  Ethyl 3-bromo-
2,2-difluoro-5-phenylpentanoate (321 mg, 1.00 mmol) and an arylzinc chloride reagent prepared 
from 1-bromo-3-methoxybenzene were used.  Solvent system for chromatography: 2:1 → 1.5:1 
hexane/dichloromethane.  The title compound was isolated as a colorless oil. 
Run 1, 271 mg (78% yield, 98% ee); Run 2, 278 mg (80% yield, 98% ee). 
The ee was determined on an AD-H column (0.25% i-PrOH/hexane, flow rate 0.5 mL/min); 
retention times for compound obtained using (R,R)-1: 22.9 min (minor), 28.8 min (major). 
1H NMR (500 MHz, CDCl3) δ 7.29 – 7.25 (m, 3H), 7.21 – 7.18 (m, 1H), 7.11 – 7.09 (m, 2H), 6.89 
– 6.82 (m, 3H), 4.13 (qd, 2H, J = 1.1, 7.2 Hz), 3.82 (s, 3H), 3.30 (dddd, 1H, J = 3.6, 11.3, 12.9, 19.6 
Hz), 2.58 (ddd, 1H, J = 4.8, 9.3, 14.0 Hz), 2.42 (ddd, 1H, J = 7.5, 9.3, 13.9 Hz), 2.28 (dddd, 1H, J = 
3.6, 7.6, 9.3, 13.1 Hz), 2.19 (dddd, 1H, J = 4.9, 9.2, 11.3, 13.9 Hz), 1.13 (t, 3H, J = 7.1 Hz); 
13C NMR (126 MHz, CDCl3) δ 163.8 (t, J = 32.8 Hz), 159.7, 141.0, 136.3 (d, J = 6.3 Hz), 129.6, 
128.39, 128.38, 126.1, 121.9, 116.5 (dd, J = 254.4, 257.5 Hz), 115.4, 113.3, 62.5, 55.2, 49.4 (dd, J = 
21.2, 23.0 Hz), 32.7, 29.2 (dd, J = 1.8, 4.6 Hz), 13.7; 
19F NMR (282 MHz, CDCl3) δ −107.1 (dd, 1F, J = 12.9, 252.1 Hz), −113.7 (dd, 1F, J = 19.6, 252.1 
Hz); 
FT-IR (film) 2940, 1771, 1602, 1490, 1456, 1257, 1103, 1064, 774, 751, 698 cm-1; 
GC-MS (EI) m/z (M+) calcd for C20H22F2O3: 348, found: 348; 
[α]25D = +27° (c = 1.05, CHCl3); 98% ee, from (R,R)-1. 
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 (S)-4-(1,1,1-Trifluoro-4-phenylbutan-2-yl)-1,1'-biphenyl.  This compound was prepared 
according to the General Procedure using (3-bromo-4,4,4-trifluorobutyl)benzene and an arylzinc 
chloride reagent prepared from 4-bromo-1,1'-biphenyl (run with (R,R)-1). 
 
  
A suitable crystal of C22H19F3 was selected for analysis.  All measurements were made on a 
Bruker APEX-II CCD with filtered Cu-Kα radiation at a temperature of 120 K.  Using Olex2,1 
the structure was solved with the ShelXS2 structure solution program using Direct Methods and 
refined with the ShelXL2 refinement package using Least Squares minimization.  The absolute 
stereochemistry was determined on the basis of the absolute structure parameter. 
 
1. Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H. J. Appl. 
Crystallogr. 2009, 42, 339. 
2. Sheldrick, G. M. Acta Crystallogr. A 2008, 64, 112. 
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Table  S–1.  Crystal  data  and  structure  refinement  for  crystal01.  
Identification  code      crystal01  
Empirical  formula      C22H19F3  
Formula  weight      340.37  
Temperature      120  K  
Wavelength      1.54178  Å  
Crystal  system      Monoclinic  
Space  group      P21  
Unit  cell  dimensions   a  =  11.0486(3)  Å   α  =  90°.  
   b  =  5.4958(2)  Å   β  =  96.3784(11)  °.  
   c  =  14.1940(4)  Å   γ  =  90  °.  
Volume   856.54(5)  Å3  
Z   2  
Density  (calculated)   1.320  Mg/m3  
Absorption  coefficient   0.814  mm-­‐‑1  
F(000)   356  
Crystal  size   0.161  x  0.036  x  0.031  mm3  
Theta  range  for  data  collection   3.133  to  71.808°.  
Index  ranges   -­‐‑13<=h<=13,  -­‐‑6<=k<=6,  -­‐‑17<=l<=17  
Reflections  collected   16914  
Independent  reflections   3123  [R(int)  =  0.0295]  
Completeness  to  theta  =  67.679°   99.9  %     
Absorption  correction   Semi-­‐‑empirical  from  equivalents  
Max.  and  min.  transmission   0.8644  and  0.7825  
Refinement  method   Full-­‐‑matrix  least-­‐‑squares  on  F2  
Data  /  restraints  /  parameters   3123  /  1  /  226  
Goodness-­‐‑of-­‐‑fit  on  F2   1.033  
Final  R  indices  [I>2sigma(I)]   R1  =  0.0282,  wR2  =  0.0776  
R  indices  (all  data)   R1  =  0.0286,  wR2  =  0.0780  
Absolute  structure  parameter  (Flack)   0.05(4)  
Largest  diff.  peak  and  hole   0.218  and  -­‐‑0.180  e/Å-­‐‑3  
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Table  S–2.  Atomic  coordinates  (  x  104)  and  equivalent  isotropic  displacement  parameters  (Å2x  
103)  for  crystal01.  U(eq)  is  defined  as  one  third  of  the  trace  of  the  orthogonalized  Uij  tensor.  
________________________________________________________________________________     
   x   y   z   U(eq)  
________________________________________________________________________________     
F(1)   4828(1)   5608(2)   2905(1)   36(1)  
F(2)   5550(1)   3642(2)   1786(1)   35(1)  
F(3)   5939(1)   7458(2)   1980(1)   33(1)  
C(1)   6808(2)   3676(4)   5793(1)   28(1)  
C(2)   6772(2)   5381(4)   6511(1)   30(1)  
C(3)   7706(2)   7058(4)   6688(1)   28(1)  
C(4)   8678(2)   7010(4)   6150(1)   28(1)  
C(5)   8705(2)   5311(4)   5426(1)   25(1)  
C(6)   7767(1)   3635(3)   5235(1)   21(1)  
C(7)   7762(2)   1825(3)   4432(1)   24(1)  
C(8)   6759(2)   2328(3)   3621(1)   22(1)  
C(9)   6939(1)   4755(3)   3122(1)   21(1)  
C(10)   5822(2)   5359(4)   2446(1)   25(1)  
C(11)   8076(1)   4830(3)   2603(1)   20(1)  
C(12)   8296(2)   3054(3)   1948(1)   26(1)  
C(13)   9316(2)   3184(3)   1457(1)   26(1)  
C(14)   10156(1)   5072(3)   1603(1)   20(1)  
C(15)   9940(2)   6825(3)   2277(1)   27(1)  
C(16)   8915(2)   6704(3)   2764(1)   26(1)  
C(17)   11251(2)   5188(3)   1073(1)   22(1)  
C(18)   11495(2)   3363(4)   441(2)   35(1)  
C(19)   12520(2)   3444(4)   -­‐‑43(2)   38(1)  
C(20)   13331(2)   5346(4)   96(1)   32(1)  
C(21)   13103(2)   7173(5)   713(2)   38(1)  
C(22)   12072(2)   7101(4)   1195(1)   34(1)  
________________________________________________________________________________  
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Table  S–3.  Bond  lengths  [Å]  and  angles  [°]  for  crystal01.  
_____________________________________________________     
F(1)-­‐‑C(10)      1.3449(19)  
F(2)-­‐‑C(10)      1.340(2)  
F(3)-­‐‑C(10)      1.343(2)  
C(1)-­‐‑C(2)      1.388(3)  
C(1)-­‐‑C(6)      1.392(2)  
C(2)-­‐‑C(3)      1.386(3)  
C(3)-­‐‑C(4)      1.386(2)  
C(4)-­‐‑C(5)      1.391(3)  
C(5)-­‐‑C(6)      1.390(3)  
C(6)-­‐‑C(7)      1.512(2)  
C(7)-­‐‑C(8)      1.533(2)  
C(8)-­‐‑C(9)      1.533(2)  
C(9)-­‐‑C(10)      1.513(2)  
C(9)-­‐‑C(11)      1.526(2)  
C(11)-­‐‑C(12)      1.388(2)  
C(11)-­‐‑C(16)      1.387(2)  
C(12)-­‐‑C(13)      1.391(2)  
C(13)-­‐‑C(14)      1.392(2)  
C(14)-­‐‑C(15)      1.397(2)  
C(14)-­‐‑C(17)      1.496(2)  
C(15)-­‐‑C(16)      1.391(2)  
C(17)-­‐‑C(18)      1.392(3)  
C(17)-­‐‑C(22)      1.387(3)  
C(18)-­‐‑C(19)      1.389(3)  
C(19)-­‐‑C(20)      1.377(3)  
C(20)-­‐‑C(21)      1.373(3)  
C(21)-­‐‑C(22)      1.392(3)  
  
C(2)-­‐‑C(1)-­‐‑C(6)   120.97(16)  
C(3)-­‐‑C(2)-­‐‑C(1)   120.03(16)  
C(2)-­‐‑C(3)-­‐‑C(4)   119.65(17)  
C(3)-­‐‑C(4)-­‐‑C(5)   120.10(17)  
C(6)-­‐‑C(5)-­‐‑C(4)   120.80(15)  
C(1)-­‐‑C(6)-­‐‑C(7)   120.04(15)  
C(5)-­‐‑C(6)-­‐‑C(1)   118.43(15)  
C(5)-­‐‑C(6)-­‐‑C(7)   121.52(15)  
C(6)-­‐‑C(7)-­‐‑C(8)   112.91(14)  
C(7)-­‐‑C(8)-­‐‑C(9)   112.59(14)  
C(10)-­‐‑C(9)-­‐‑C(8)   110.19(14)  
C(10)-­‐‑C(9)-­‐‑C(11)   110.23(13)  
C(11)-­‐‑C(9)-­‐‑C(8)   113.71(13)  
F(1)-­‐‑C(10)-­‐‑C(9)   111.55(14)  
F(2)-­‐‑C(10)-­‐‑F(1)   106.19(15)  
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F(2)-­‐‑C(10)-­‐‑F(3)   106.70(13)  
F(2)-­‐‑C(10)-­‐‑C(9)   113.11(14)  
F(3)-­‐‑C(10)-­‐‑F(1)   106.23(15)  
F(3)-­‐‑C(10)-­‐‑C(9)   112.58(15)  
C(12)-­‐‑C(11)-­‐‑C(9)   121.26(15)  
C(16)-­‐‑C(11)-­‐‑C(9)   120.77(14)  
C(16)-­‐‑C(11)-­‐‑C(12)   117.96(15)  
C(11)-­‐‑C(12)-­‐‑C(13)   120.75(16)  
C(12)-­‐‑C(13)-­‐‑C(14)   121.83(16)  
C(13)-­‐‑C(14)-­‐‑C(15)   116.98(15)  
C(13)-­‐‑C(14)-­‐‑C(17)   121.35(15)  
C(15)-­‐‑C(14)-­‐‑C(17)   121.65(15)  
C(16)-­‐‑C(15)-­‐‑C(14)   121.17(16)  
C(11)-­‐‑C(16)-­‐‑C(15)   121.28(16)  
C(18)-­‐‑C(17)-­‐‑C(14)   121.23(16)  
C(22)-­‐‑C(17)-­‐‑C(14)   121.62(15)  
C(22)-­‐‑C(17)-­‐‑C(18)   117.14(16)  
C(19)-­‐‑C(18)-­‐‑C(17)   121.47(19)  
C(20)-­‐‑C(19)-­‐‑C(18)   120.45(19)  
C(21)-­‐‑C(20)-­‐‑C(19)   118.95(17)  
C(20)-­‐‑C(21)-­‐‑C(22)   120.7(2)  
C(17)-­‐‑C(22)-­‐‑C(21)   121.30(19)  
_____________________________________________________________     
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Table  S–4.  Anisotropic  displacement  parameters  (Å2x  103)  for  crystal01.      The  anisotropic  
displacement  factor  exponent  takes  the  form:  -­‐‑2π2[  h2  a*2U11  +  ...  +  2  h  k  a*  b*  U12  ]  
______________________________________________________________________________     
   U11   U22      U33   U23   U13   U12  
______________________________________________________________________________     
F(1)   26(1)      48(1)   37(1)      3(1)   10(1)      10(1)  
F(2)   32(1)      39(1)   33(1)      -­‐‑11(1)   -­‐‑7(1)      4(1)  
F(3)   35(1)      32(1)   32(1)      8(1)   2(1)      6(1)  
C(1)   29(1)      30(1)   25(1)      -­‐‑3(1)   5(1)      -­‐‑5(1)  
C(2)   28(1)      37(1)   25(1)      -­‐‑4(1)   7(1)      1(1)  
C(3)   33(1)      28(1)   20(1)      -­‐‑4(1)   -­‐‑1(1)      5(1)  
C(4)   29(1)      29(1)   26(1)      -­‐‑1(1)   -­‐‑2(1)      -­‐‑4(1)  
C(5)   24(1)      30(1)   21(1)      2(1)   2(1)      0(1)  
C(6)   26(1)      20(1)   18(1)      2(1)   0(1)      4(1)  
C(7)   31(1)      19(1)   22(1)      0(1)   4(1)      3(1)  
C(8)   27(1)      21(1)   21(1)      -­‐‑2(1)   4(1)      -­‐‑1(1)  
C(9)   24(1)      20(1)   19(1)      -­‐‑3(1)   4(1)      1(1)  
C(10)   26(1)      25(1)   25(1)      -­‐‑1(1)   5(1)      4(1)  
C(11)   23(1)      20(1)   17(1)      0(1)   2(1)      2(1)  
C(12)   27(1)      25(1)   27(1)      -­‐‑8(1)   5(1)      -­‐‑4(1)  
C(13)   31(1)      24(1)   25(1)      -­‐‑10(1)   6(1)      -­‐‑2(1)  
C(14)   24(1)      20(1)   16(1)      4(1)   0(1)      3(1)  
C(15)   31(1)      19(1)   32(1)      -­‐‑5(1)   8(1)      -­‐‑4(1)  
C(16)   33(1)      19(1)   27(1)      -­‐‑7(1)   8(1)      0(1)  
C(17)   24(1)      24(1)   16(1)      6(1)   0(1)      4(1)  
C(18)   41(1)      27(1)   39(1)      -­‐‑6(1)   17(1)      -­‐‑3(1)  
C(19)   46(1)      33(1)   40(1)      -­‐‑3(1)   22(1)      3(1)  
C(20)   26(1)      43(1)   27(1)      10(1)   6(1)      8(1)  
C(21)   30(1)      47(1)   38(1)      -­‐‑1(1)   7(1)      -­‐‑9(1)  
C(22)   32(1)      37(1)   32(1)      -­‐‑8(1)   8(1)      -­‐‑5(1)  
______________________________________________________________________________  
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Table  S–5.  Hydrogen  coordinates  (  x  104)  and  isotropic  displacement  parameters  (Å2x  10  3)  
for  crystal01.  
________________________________________________________________________________     
   x      y      z      U(eq)  
________________________________________________________________________________     
     
H(1)   6168   2521   5681   33  
H(2)   6107   5397   6882   36  
H(3)   7679   8236   7175   33  
H(4)   9327   8138   6276   34  
H(5)   9372   5296   5058   30  
H(7A)   7650   168   4682   28  
H(7B)   8563   1872   4182   28  
H(8A)   5960   2345   3875   27  
H(8B)   6747   993   3151   27  
H(9)   7027   6050   3619   25  
H(12)   7744   1734   1834   31  
H(13)   9442   1952   1009   32  
H(15)   10502   8122   2406   33  
H(16)   8787   7929   3214   32  
H(18)   10947   2033   337   42  
H(19)   12663   2177   -­‐‑472   46  
H(20)   14037   5395   -­‐‑229   38  
H(21)   13654   8499   811   46  
H(22)   11929   8388   1615   40  












A  suitable  crystal  of  C23H20F2O  was  selected  for  analysis.      All  measurements  were  made  on  
a  Bruker  APEX-­‐‑II  CCD  with  filtered  Cu-­‐‑Kα  radiation  at  a  temperature  of  120  K.      Using  Olex2,1  
the  structure  was  solved  with  the  ShelXS2  structure  solution  program  using  Direct  Methods  and  
refined  with  the  ShelXL2  refinement  package  using  Least  Squares  minimization.      The  absolute  
stereochemistry  was  determined  on  the  basis  of  the  absolute  structure  parameter.  
  
1. Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H. J. Appl. 
Crystallogr. 2009, 42, 339. 
2. Sheldrick, G. M. Acta Crystallogr. A 2008, 64, 112. 
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Table  S–6.  Crystal  data  and  structure  refinement  for  crystal02.  
Identification  code      crystal02  
Empirical  formula      C23H20F2O  
Formula  weight      350.39  
Temperature      120  K  
Wavelength      1.54178  Å  
Crystal  system      Orthorhombic  
Space  group      P212121  
Unit  cell  dimensions   a  =  5.66013(10)  Å   α  =  90°.  
   b  =  13.3182(2)  Å   β  =  90  °.  
   c  =  23.7538(4)  Å   γ  =  90  °.  
Volume   1790.63(5)  Å3  
Z   4  
Density  (calculated)   1.300  Mg/m3  
Absorption  coefficient   0.755  mm-­‐‑1  
F(000)   736  
Crystal  size   0.133  x  0.057  x  0.012  mm3  
Theta  range  for  data  collection   3.721  to  71.834°.  
Index  ranges   -­‐‑6<=h<=6,  -­‐‑16<=k<=16,  -­‐‑28<=l<=29  
Reflections  collected   21566  
Independent  reflections   3486  [R(int)  =  0.0407]  
Completeness  to  theta  =  67.679°   99.8  %     
Absorption  correction   Semi-­‐‑empirical  from  equivalents  
Max.  and  min.  transmission   0.7535  and  0.6828  
Refinement  method   Full-­‐‑matrix  least-­‐‑squares  on  F2  
Data  /  restraints  /  parameters   3486  /  0  /  235  
Goodness-­‐‑of-­‐‑fit  on  F2   1.061  
Final  R  indices  [I>2sigma(I)]   R1  =  0.0280,  wR2  =  0.0726  
R  indices  (all  data)   R1  =  0.0290,  wR2  =  0.0734  
Absolute  structure  parameter  (Flack)   0.04(4)  
Largest  diff.  peak  and  hole   0.158  and  -­‐‑0.181  e/Å-­‐‑3  
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Table  S–7.  Atomic  coordinates  (  x  104)  and  equivalent  isotropic  displacement  parameters  (Å2x  103)  
for  crystal02.  U(eq)  is  defined  as  one  third  of  the  trace  of  the  orthogonalized  Uij  tensor.  
________________________________________________________________________________     
   x   y   z   U(eq)  
________________________________________________________________________________     
F(1)   1883(2)   3098(1)   -­‐‑253(1)   23(1)  
F(2)   4614(2)   3949(1)   181(1)   23(1)  
O(1)   4293(2)   5356(1)   -­‐‑544(1)   25(1)  
C(1)   -­‐‑1167(3)   4179(1)   -­‐‑1024(1)   21(1)  
C(2)   -­‐‑2795(3)   4277(1)   -­‐‑1456(1)   25(1)  
C(3)   -­‐‑2562(3)   5041(2)   -­‐‑1850(1)   27(1)  
C(4)   -­‐‑679(4)   5708(1)   -­‐‑1815(1)   27(1)  
C(5)   975(3)   5605(1)   -­‐‑1391(1)   23(1)  
C(6)   749(3)   4842(1)   -­‐‑989(1)   18(1)  
C(7)   2613(3)   4794(1)   -­‐‑546(1)   18(1)  
C(8)   2411(3)   4046(1)   -­‐‑52(1)   18(1)  
C(9)   621(3)   4361(1)   396(1)   17(1)  
C(10)   977(3)   5461(1)   551(1)   16(1)  
C(11)   2992(3)   5781(1)   839(1)   19(1)  
C(12)   3298(3)   6793(1)   964(1)   21(1)  
C(13)   1600(3)   7492(1)   810(1)   21(1)  
C(14)   -­‐‑401(3)   7179(1)   524(1)   22(1)  
C(15)   -­‐‑717(3)   6166(1)   394(1)   19(1)  
C(16)   719(3)   3646(1)   903(1)   20(1)  
C(17)   -­‐‑1172(3)   3896(1)   1344(1)   23(1)  
C(18)   -­‐‑1094(3)   3172(1)   1833(1)   20(1)  
C(19)   -­‐‑2859(3)   2457(1)   1908(1)   25(1)  
C(20)   -­‐‑2738(4)   1764(1)   2343(1)   30(1)  
C(21)   -­‐‑835(4)   1774(1)   2711(1)   30(1)  
C(22)   919(4)   2488(2)   2645(1)   28(1)  
C(23)   796(3)   3182(1)   2210(1)   24(1)  
________________________________________________________________________________  
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Table  S–8.      Bond  lengths  [Å]  and  angles  [°]  for  crystal02.  
_____________________________________________________     
F(1)-­‐‑C(8)      1.3822(18)  
F(2)-­‐‑C(8)      1.3698(18)  
O(1)-­‐‑C(7)      1.211(2)  
C(1)-­‐‑C(2)      1.386(2)  
C(1)-­‐‑C(6)      1.401(2)  
C(2)-­‐‑C(3)      1.388(3)  
C(3)-­‐‑C(4)      1.390(3)  
C(4)-­‐‑C(5)      1.382(3)  
C(5)-­‐‑C(6)      1.400(2)  
C(6)-­‐‑C(7)      1.491(2)  
C(7)-­‐‑C(8)      1.545(2)  
C(8)-­‐‑C(9)      1.527(2)  
C(9)-­‐‑C(10)      1.524(2)  
C(9)-­‐‑C(16)      1.536(2)  
C(10)-­‐‑C(11)      1.396(2)  
C(10)-­‐‑C(15)      1.393(2)  
C(11)-­‐‑C(12)      1.391(2)  
C(12)-­‐‑C(13)      1.389(2)  
C(13)-­‐‑C(14)      1.384(3)  
C(14)-­‐‑C(15)      1.396(2)  
C(16)-­‐‑C(17)      1.535(2)  
C(17)-­‐‑C(18)      1.511(2)  
C(18)-­‐‑C(19)      1.392(2)  
C(18)-­‐‑C(23)      1.394(2)  
C(19)-­‐‑C(20)      1.387(3)  
C(20)-­‐‑C(21)      1.388(3)  
C(21)-­‐‑C(22)      1.383(3)  
C(22)-­‐‑C(23)      1.389(3)  
  
C(2)-­‐‑C(1)-­‐‑C(6)   119.93(16)  
C(1)-­‐‑C(2)-­‐‑C(3)   120.33(17)  
C(2)-­‐‑C(3)-­‐‑C(4)   120.08(17)  
C(5)-­‐‑C(4)-­‐‑C(3)   119.95(17)  
C(4)-­‐‑C(5)-­‐‑C(6)   120.49(16)  
C(1)-­‐‑C(6)-­‐‑C(7)   124.17(15)  
C(5)-­‐‑C(6)-­‐‑C(1)   119.21(16)  
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C(5)-­‐‑C(6)-­‐‑C(7)   116.62(15)  
O(1)-­‐‑C(7)-­‐‑C(6)   122.16(15)  
O(1)-­‐‑C(7)-­‐‑C(8)   116.94(15)  
C(6)-­‐‑C(7)-­‐‑C(8)   120.84(14)  
F(1)-­‐‑C(8)-­‐‑C(7)   109.98(12)  
F(1)-­‐‑C(8)-­‐‑C(9)   110.34(13)  
F(2)-­‐‑C(8)-­‐‑F(1)   104.46(12)  
F(2)-­‐‑C(8)-­‐‑C(7)   107.49(13)  
F(2)-­‐‑C(8)-­‐‑C(9)   110.44(12)  
C(9)-­‐‑C(8)-­‐‑C(7)   113.69(13)  
C(8)-­‐‑C(9)-­‐‑C(16)   110.57(13)  
C(10)-­‐‑C(9)-­‐‑C(8)   110.17(13)  
C(10)-­‐‑C(9)-­‐‑C(16)   113.65(13)  
C(11)-­‐‑C(10)-­‐‑C(9)   121.34(14)  
C(15)-­‐‑C(10)-­‐‑C(9)   119.48(14)  
C(15)-­‐‑C(10)-­‐‑C(11)   119.17(15)  
C(12)-­‐‑C(11)-­‐‑C(10)   120.19(15)  
C(13)-­‐‑C(12)-­‐‑C(11)   120.46(16)  
C(14)-­‐‑C(13)-­‐‑C(12)   119.58(16)  
C(13)-­‐‑C(14)-­‐‑C(15)   120.33(15)  
C(10)-­‐‑C(15)-­‐‑C(14)   120.27(15)  
C(17)-­‐‑C(16)-­‐‑C(9)   112.08(13)  
C(18)-­‐‑C(17)-­‐‑C(16)   111.50(13)  
C(19)-­‐‑C(18)-­‐‑C(17)   120.90(15)  
C(19)-­‐‑C(18)-­‐‑C(23)   118.43(16)  
C(23)-­‐‑C(18)-­‐‑C(17)   120.63(15)  
C(20)-­‐‑C(19)-­‐‑C(18)   120.97(17)  
C(19)-­‐‑C(20)-­‐‑C(21)   120.07(18)  
C(22)-­‐‑C(21)-­‐‑C(20)   119.53(17)  
C(21)-­‐‑C(22)-­‐‑C(23)   120.38(18)  
C(22)-­‐‑C(23)-­‐‑C(18)   120.61(17)  
_____________________________________________________________     
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Table  S–9.      Anisotropic  displacement  parameters  (Å2x  103)  for  crystal02.      The  anisotropic  
displacement  factor  exponent  takes  the  form:  -­‐‑2π2[  h2  a*2U11  +  ...  +  2  h  k  a*  b*  U12  ]  
______________________________________________________________________________     
   U11   U22      U33   U23   U13   U12  
______________________________________________________________________________     
F(1)   27(1)      13(1)   29(1)      -­‐‑4(1)   1(1)      0(1)  
F(2)   15(1)      24(1)   29(1)      0(1)   -­‐‑1(1)      5(1)  
O(1)   22(1)      24(1)   28(1)      -­‐‑2(1)   3(1)      -­‐‑7(1)  
C(1)   22(1)      20(1)   22(1)      -­‐‑3(1)   3(1)      -­‐‑1(1)  
C(2)   22(1)      27(1)   26(1)      -­‐‑7(1)   0(1)      0(1)  
C(3)   28(1)      30(1)   24(1)      -­‐‑4(1)   -­‐‑4(1)      8(1)  
C(4)   35(1)      22(1)   24(1)      2(1)   1(1)      5(1)  
C(5)   25(1)      18(1)   25(1)      -­‐‑1(1)   4(1)      0(1)  
C(6)   19(1)      17(1)   20(1)      -­‐‑4(1)   3(1)      2(1)  
C(7)   18(1)      16(1)   21(1)      -­‐‑5(1)   5(1)      0(1)  
C(8)   14(1)      15(1)   24(1)      -­‐‑4(1)   -­‐‑1(1)      0(1)  
C(9)   14(1)      17(1)   20(1)      -­‐‑1(1)   0(1)      1(1)  
C(10)   14(1)      18(1)   17(1)      -­‐‑1(1)   2(1)      1(1)  
C(11)   17(1)      20(1)   21(1)      -­‐‑2(1)   -­‐‑3(1)      4(1)  
C(12)   20(1)      23(1)   22(1)      -­‐‑2(1)   -­‐‑1(1)      -­‐‑1(1)  
C(13)   25(1)      16(1)   22(1)      -­‐‑2(1)   3(1)      0(1)  
C(14)   22(1)      19(1)   25(1)      0(1)   0(1)      6(1)  
C(15)   16(1)      20(1)   21(1)      -­‐‑1(1)   -­‐‑1(1)      2(1)  
C(16)   19(1)      17(1)   22(1)      1(1)   1(1)      1(1)  
C(17)   21(1)      25(1)   24(1)      2(1)   2(1)      4(1)  
C(18)   19(1)      20(1)   21(1)      -­‐‑2(1)   4(1)      2(1)  
C(19)   21(1)      25(1)   29(1)      -­‐‑5(1)   3(1)      -­‐‑1(1)  
C(20)   30(1)      22(1)   39(1)      -­‐‑2(1)   14(1)      -­‐‑5(1)  
C(21)   43(1)      24(1)   24(1)      3(1)   11(1)      5(1)  
C(22)   35(1)      31(1)   20(1)      -­‐‑1(1)   -­‐‑2(1)      4(1)  
C(23)   24(1)      24(1)   25(1)      -­‐‑3(1)   0(1)      -­‐‑5(1)  
______________________________________________________________________________  
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Table  S–10.      Hydrogen  coordinates  (  x  104)  and  isotropic  displacement  parameters  (Å2x  10  3)  
for  crystal02.  
________________________________________________________________________________     
   x      y      z      U(eq)  
________________________________________________________________________________     
     
H(1)   -­‐‑1351   3663   -­‐‑751   25  
H(2)   -­‐‑4076   3818   -­‐‑1484   30  
H(3)   -­‐‑3692   5109   -­‐‑2143   33  
H(4)   -­‐‑527   6233   -­‐‑2083   33  
H(5)   2274   6055   -­‐‑1372   28  
H(9)   -­‐‑987   4298   225   20  
H(11)   4158   5307   948   23  
H(12)   4679   7006   1158   26  
H(13)   1810   8182   899   25  
H(14)   -­‐‑1565   7656   417   27  
H(15)   -­‐‑2092   5957   197   23  
H(16A)   488   2948   771   23  
H(16B)   2300   3688   1079   23  
H(17A)   -­‐‑918   4588   1485   28  
H(17B)   -­‐‑2753   3869   1167   28  
H(19)   -­‐‑4165   2443   1657   30  
H(20)   -­‐‑3961   1282   2389   36  
H(21)   -­‐‑736   1293   3005   36  
H(22)   2214   2503   2899   34  
































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 3, Entry 11
13C NMR
(CDCl3, 126 MHz)
0123456789
1.
00
1.
02
1.
03
1.
03
1.
00
2.
82
0.
90
1.
79
1.
79
0.
89
2.
67
S–
93
PhF3C
OMe
Eq 3
1H NMR
(CDCl3, 500 MHz)
020406080100120140160180200
S–
94
PhF3C
OMe
Eq 3
13C NMR
(CDCl3, 126 MHz)
0123456789
0.
99
2.
04
1.
04
1.
00
3.
02
0.
96
1.
91
1.
88
0.
92
2.
83
S–
95
n-C3F7 Ph
OMe
Eq 4
1H NMR
(CDCl3, 500 MHz)
020406080100120140160180200
S–
96
n-C3F7 Ph
OMe
Eq 4
13C NMR
(CDCl3, 126 MHz)
0123456789
1.
02
2.
00
1.
04
1.
00
2.
89
1.
80
1.
83
4.
72
S–
97
ClF2C Ph
OMe
Eq 5
1H NMR
(CDCl3, 500 MHz)
020406080100120140160180200
S–
98
ClF2C Ph
OMe
Eq 5
13C NMR
(CDCl3, 126 MHz)
0123456789
1.
02
2.
05
1.
02
1.
00
1.
89
0.
93
6.
84
1.
91
0.
94
1.
86
S–
99
Ph
PhPh
F F
O
Eq 6
1H NMR
(CDCl3, 500 MHz)
020406080100120140160180200
S–
10
0
Ph
PhPh
F F
O
Eq 6
13C NMR
(CDCl3, 126 MHz)
0123456789
2.
78
1.
00
1.
03
1.
04
1.
03
1.
00
2.
98
1.
87
2.
89
1.
91
0.
93
2.
99
S–
10
1
PhEtO
F F
O
OMe
Eq 7
1H NMR
(CDCl3, 500 MHz)
020406080100120140160180200
S–
10
2
PhEtO
F F
O
OMe
Eq 7
13C NMR
(CDCl3, 126 MHz)
